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Abstract 
Millions of individuals suffer disability or death from immune-based inflammatory 
diseases. If psychiatric disorders could be empirically linked to the prediction of immune-
based inflammatory diseases, there would be a basis for promoting disease prevention 
measures for individuals diagnosed with one of four psychiatric disorders. 
Psychoneuroimmunology provided the theoretical base for understanding emotionally 
induced medical disease development. In this quantitative study, a parallel archival 
research design was used to investigate the degree to which generalized anxiety disorder, 
posttraumatic stress disorder, major depression recurrent, and dysthymic disorder 
predicted the presence of atherosclerosis, cardiovascular heart disease, rheumatoid 
arthritis, cancer, and type II diabetes. There were 1,209 electronic medical records of 
adult patients obtained through purposive stratified sampling.  A secondary data analysis 
was employed using descriptive cross tabulation, chi-square test of independence, and 
multinomial logistic regression. The findings revealed major depression recurrent was a 
statistically significant predictor for atherosclerosis, rheumatoid arthritis, type II diabetes 
and cancer. Generalized anxiety disorder was a statistically significant predictor for 
cancer. The results can promote positive social change by providing information that 
could be used to develop assessment plans that identity individuals who are at risk of 
developing the comorbid diseases. The prevention programs could effectively be used to 
minimize the subsequent development of inflammatory diseases, which in turn could 
decrease the onset of the medical diseases among individuals with psychiatric disorders. 
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Dedication 
Fear thou not; for I am with thee: be not dismayed; for I am thy God: I will strengthen 
thee; yes, I will help thee; yes, I will uphold thee with the right hand of my righteousness. 
                                 Isaiah 41:10 
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Chapter 1 
Millions of people in the United States and world-wide suffer from at least one of 
the inflammatory-based medical diseases of atherosclerosis, cardiovascular heart disease, 
rheumatoid arthritis, cancer, or type II diabetes (Heijnen & Kavelaars, 2005; Pickup, 
2003; Steptoe & Brydon, 2005; Walker, Green, Greenman, Walker, & Sharpe, 2005). 
Many of these individuals also have at least one of the psychiatric diagnoses of 
generalized anxiety disorder, posttraumatic stress disorder, major depression, recurrent, 
or dysthymic disorder (DSM-IV, 2000). This study investigated these psychiatric and 
medical comorbid conditions to determine if the psychiatric disorders predicted the 
presence of the medical diseases. The multidisciplinary field of psychoneuroimmunology 
(PNI) provides a theoretical foundation for understanding the connection between the 
psychiatric condition of the individual and the initiation of the acute inflammatory 
response. PNI serves as the basis for explaining the development of the medical diseases 
included in this study (Rabin, 2005). The purpose of this study was to determine if one or 
more of the psychiatric disorders of generalized anxiety disorder, posttraumatic stress 
disorder, major depression recurrent, or dysthymic disorder could be used to predict the 
presence one or more of the inflammatory based medical diseases of atherosclerosis, 
cardiovascular heart disease, rheumatoid arthritis, cancer, or type II diabetes. 
Chapter 2 will provide detail of the 138 year history of scientific and clinical 
documentation of the PNI psychobiological process involved in the development of 
atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and type II 
diabetes. This chapter, however, will provide the presentation of the problem statement, 
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nature of the study with the research questions, purpose of the study, theoretical 
framework, operational definitions, assumptions and limitations of the study, significance 
of the study, professional application of the results, and positive social change. This 
chapter will conclude with a summary of the chapter and an introduction to the remaining 
four chapters of the study: the literature review, methodology, data analysis, and 
discussion of the findings. 
Problem Statement 
Individuals with psychiatric and medical disease comorbidity lose 25 to 30 years 
of normal life expectancy (Malliori, 2010). Over 70% of patients with severe decrements 
in their quality of life suffer from psychiatric and medical comorbid conditions 
(Moussavi, 2007). Depression and anxiety affect up to 25% of the female population in 
the United States and up to 12% of the male population in the United States (DSM-VI). 
Specifically, the affective disorders included in this study were generalized anxiety 
disorder, posttraumatic stress disorder, major depression recurrent, and dysthymic 
disorder. The medical diseases in the comorbid conditions investigated in this study were 
atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and type II 
diabetes. Prevalence studies involving cardiovascular heart disease and stroke report 71.3 
million adults in the United States suffer disability or death annually (Mensah & Brown, 
2007). There are 12.5 million individuals in the United States diagnosed with 
atherosclerosis (Pearson, 2007). Sixty-eight million individuals suffer the debilitating 
disease of rheumatoid arthritis (Heijnen & Kavelaars, 2005). There are 500,000 deaths 
annually because of cancer (University of Rochester, 2007). There are 100 million 
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individuals suffering with type II diabetes (Pickup & Crook, 1998). Mensah and Brown 
(2007) also reported that inflammatory-based diseases resulted in a healthcare cost 
burden that exceeds $400 billion a year for individuals and society. The rising personal 
and financial costs associated with the comorbid conditions indicate the need to identify 
additional predictors of these inflammatory based diseases for use in disease prevention 
assessments (Spiegel, 2003).  
Psychoneuroimmunology (PNI) provides the scientific bases for including the 
psychiatric disorders as predictors of the medical diseases (Boscarino, 1997; Ford et al. 
1998, Wells et al., 1991). PNI research has revealed that prolonged emotional distress, as 
with depression and anxiety, results in hormonal changes that causes a dysregulation in 
some cellular functions and alters immune function (Rabin, 2005). Studies using the PNI 
model have provided evidence showing that the immune parameters supporting the 
inflammatory-based disease process can be significantly altered by use of psychotherapy. 
However the change in the immune parameters have no effect on the disease process 
once the disease has been initiated (Cupal, Brewer, & Britton, 2001; Donaldson, 2000; 
Gruber et al., 1993; Gruber, Hall, & Hersh, 1988; Hall et al., 1996; Kraaimaat et al., 
1995; Laidlaw, Booth, & Large, 1996; Luskin, 2008; Lutgendorf et al., 2000; Pawlow & 
Jones, 2002; Petrie et al., 1995; Sherman et al., 1997; Surwit et al., 1991; Van der Pompe 
et al., 1997; Witvliet et al., 2001). A detailed discussion of these studies is provided in 
chapter 2. However the common focus of each of the studies was to investigate the use of 
psychotherapy for disease amelioration or reversal. Prior to the studies by Ader and 
Cohen (1975) which demonstrated that the immune system can respond to classical 
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conditioning, the potential of psychotherapy was viewed as predominantly palliative 
(Spiegel, 2003). Subsequent PNI researchers have substantiated the findings by Ader and 
Cohen. This presents the possibility of going beyond palliative care to help individuals 
cope with the distress of illness, to investigating the role of psychotherapy in disease 
prevention. The findings of the studies investigating the effect of psychotherapy 
techniques with existing disease processes revealed the problem of identifying the time 
between the occurrence of the first diagnosis in the comorbid pair and the occurrence of 
the second diagnosis so that psychotherapy interventions could be utilized in prevention 
treatment. This is an important area of exploration. Mensah and Brown (2007) reported 
the problem of underuse of prevention strategies that result in less than optimal control of 
the risk factors in inflammatory diseases. Kiecolt-Glaser et al. (2002) reported a problem 
in the lack of pre-clinical information necessary to explore the efficacy of psychotherapy 
as a prevention treatment. 
Nature of the Study 
This research was predicated by PNI studies conducted by previous researchers 
(Batstra, Bos, & Neeleman, 2002; Boscarino, 1997; Ford et al., 1998; Kiecolt-Glaser et 
al., 2002). This study tested the hypothesis that a predictive relationship exists between 
psychiatric disorders and inflammatory based medical diseases, and that psychiatric 
disorders are predictors for specific medical diseases. The specific research questions for 
this study were: 
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1. For individuals with comorbid psychiatric disorder and medical disease 
diagnoses, what is the association between the first type of psychiatric diagnosis and the 
first medical diagnosis? 
2. Among individuals with comorbid psychiatric and medical disease diagnoses, 
to what degree does the presence of a psychiatric disorder and the demographic variables 
(gender, race, family psychiatric history, family medical history, and chemical 
dependence history) significantly predict the presence of the medical disorders 
atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and type II 
diabetes in the comorbid pairs? 
3. To what degree does the presence of a psychiatric disorder as the first diagnosis 
and the diagnosed psychiatric disorder predict the medical disorders for the comorbid 
pairs included in the study? 
This study used several statistical methods to test the null hypotheses for the 
research questions. A descriptive cross tabulation was used to address research question 
1. The chi-square test of independence was used to address research question 2, and the 
multinomial logistic regression was used to address research question 3. 
The design of this study addressed some of the problems cited by previous 
researchers who used an archival research design. The researchers reported that, among 
the studies they reviewed, there was a broad diversity in the type of research designs 
selected, study inclusion criterions used, and different variables investigated in the 
studies, which made it difficult to generalize the findings. The broad diversity in 
reporting the results for the studies was also viewed as problematic in generalizing the 
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findings (Baumeister et al., 2005; Kiecolt-Glaser et al., 2002; Moussavi et al., 2007). 
Finally, the researchers reported the lack of verification of psychiatric and medical 
diagnoses as problematic regarding the reliability of the findings reported. The 
researchers reported the studies that they reviewed relied on participant self-reports, 
which may have confounded the findings. This study specifically addressed the 
methodological problems that affected the generalizability reported by previous 
researchers by using clinically determined diagnoses for all of the cases included in the 
study. This study employed a purposive stratified sampling method (Trochim, 2006). 
This allowed for the selection of cases with specific psychiatric disorders and specific 
medical diseases. The process involved accessing and reviewing patient electronic 
medical records using the codes from the Diagnostic and Statistical Manual of Mental 
Disorders, 4th edition (DSM-IV) for the psychiatric disorders investigated in the study 
and then using the diagnostic codes from the International Classification of Diseases, 9th 
Revision (ICD-9) for the medical diseases. An additional way in which the design of this 
study improved upon previous archival studies was the uniformity of clinical 
documentation. This uniformity was accomplished by the selection of a single healthcare 
system from which to draw the cases. The healthcare system has a strict clinical 
documentation policy to assure uniformity across the multiple hospitals in the system 
(HFHS Clinical Documentation Policy and Procedures, 1997-revision). 
Purpose of the Study 
The purpose of this study was to determine if certain psychiatric disorders 
predicted the presence of specific immune-based inflammatory diseases. The premise 
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was if psychiatric disorders could be empirically linked to the prediction of immune-
based inflammatory diseases, then there would be a basis for developing and promoting 
disease prevention measures for individuals diagnosed with one of the four psychiatric 
disorders. The goal of the intervention programs would be to reduce the likelihood of the 
individuals developing one of the five inflammatory based medical diseases investigated 
in this study. The psychiatric predictor disorders in this study were generalized anxiety 
disorder, posttraumatic stress disorder, major depression recurrent, and dysthymic 
disorder. The five medical diseases investigated in this study were atherosclerosis, 
cardiovascular heart disease, rheumatoid arthritis, cancer, and type II diabetes as the 
dependent variables. The statistical method that was used to test the prediction model was 
multinomial logistic regression. 
This study also addressed the shortcomings of previous research by considering 
the influence of certain demographic and biological factors on the prediction model. The 
demographic variables included age, race, and gender. Several researchers (Baumeister et 
al., 2005; Kiecolt-Glaser et al. 2002; Moussavi et al., 2007) have suggested the 
importance of including such variables when studying the PNI model as it relates to 
comorbid psychiatric and medical conditions. The biological factors also included family 
history of psychiatric disorder, family history of the medical disorder, and individual 
history of chemical dependence. Kiecolt-Glaser et al. (2002) had suggested the 
importance of including chemical dependence history in studies of comorbid occurrences 
of psychiatric and medical conditions because of its negative effect on both mental and 
8 
 
 
  
physical health. Pinel (2006) recently reported the prevalence of chemical dependence 
among individuals suffering from comorbid conditions. 
For this study, I obtained the medical and psychiatric information identified as 
significant in the comorbid pairing by previous PNI researchers (Kiecolt-Glaser et al., 
2002; Kaye and Lightman, 2005; and Rabin, 2005). To test the hypotheses that certain 
psychiatric disorders predict the presence of specific immune based inflammatory 
diseases, this study reviewed 1,209 electronic medical records of patients treated in a 
multi-hospital healthcare system. The hospital system has uniform patient assessment 
protocols, full documentation of the medical and psychiatric diagnoses, and documented 
treatment histories for the patients. A purposive sampling approach was used to assure 
only the medical records that met the inclusion criterion were reviewed for the study. The 
inclusion criterion was that the records were of individuals who were 21 years of age or 
older, and the individuals must have at least one of the identified psychiatric disorders 
plus at least one of the identified medical diseases. Chapter 3 will provide greater detail 
of the research design. 
Theoretical Framework 
Psychoneuroimmunology (PNI) is an interdisciplinary field involving the 
scientific investigation of how emotions affect the functioning of the central nervous 
system. In response to prolonged emotional distress, such as depression or anxiety 
disorders, the hypothalamus secretes the hormone corticotrophin releasing factor (CRF). 
The CRF causes the increased production of the hormones epinephrine, norepinephrine, 
and cortisol. Over time, if the emotional distress continues, these hormonal changes cause 
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a dysregulation in some cellular functions and in the immune system. The hormonal 
changes can ultimately form the bases for the development of some medical diseases 
(Kaye & Lightman, 2005; Kiecolt-Glaser, 2002; Rabin, 2005). It is the interrelated action 
of cellular dysregulation and immune system dysregulation that results in the 
inflammatory response by the immune system. A review of the literature revealed anxiety 
and depression to be the most consistent psychiatric disorders to initiate the dysregulation 
process that results in the acute inflammatory response, which has been linked to the 
development of certain medical diseases (Kiecolt-Glaser et al., 2002; Rabin, 2005). From 
the broad categories of anxiety and depression, this study specifically selected the 
psychiatric diagnoses of generalized anxiety disorder, posttraumatic stress disorder, 
major depression recurrent, and dysthymic disorder. The medical conditions included in 
this study were atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, 
and type II diabetes. 
In general, at the center of the stress response is the increased production of the 
hormones cortisol, epinephrine, and norepinephrine. These hormones contribute to the 
initiation of the acute inflammatory response that can eventually progress to the immune 
inflammatory reaction (McCance & Huether, 2002; Rabin, 2005). For instance, 
atherosclerosis is the result of the inflammatory response within the blood vessels and 
cardiovascular heart disease develops subsequent to atherosclerosis (Steptoe & Brydon, 
2005). Rheumatoid arthritis results from an inflammatory response that destroys the body 
tissue that lines the joints. It also reflects the failure of the immune system to recognize 
the body’s own cells (Heijnen & Kavelaars, 2005). Cancer is the failure of the immune 
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system to detect and destroy mutated self- cells by the inflammatory response (Walker et 
al., 2005). Type II diabetes is the impairment of the insulin secretion of the beta cells of 
the pancreas that occurs over time, initially triggered by the acute inflammatory response 
which was precipitated by prolonged emotional states of anxiety and/or depression 
(Pickup & Crook, 1997).Figure 1 presents a diagram of the PNI bases for psychiatric 
disorder and medical disease comorbidity. In figure 1, in the formation of psychiatric and 
medical disease comorbidity, the emotional experience initiates the physiological 
response by the endocrine system to alter hormonal output that becomes the foundation 
for the medical disease (Kaye & Lightman, 2005; Kiecolt-Glaser, 2002; Rabin, 2005). 
 
Figure 1.  Pyschoneuroimmunology comorbidity model. 
 
Seminal studies by Solomon and Moos (1963) provided the first evidence of the 
immune response to prolonged stress. Ader and Cohen (1975) demonstrated that the 
immune system can respond to classical conditioning. Experimental research designs 
using relaxation therapy techniques have shown the immune parameters of the 
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inflammatory disease processes can be significantly altered through the use of stress 
reduction techniques (Donaldson, 2000; Gruber, Hall, & Hersh, 1988; Gruber, Hersh, 
Hall, Waletzky, Kunz, & Weiss, 1993). Although these studies noted the immune 
function was altered, they also noted that existing medical diseases continued to progress 
despite the change in the inflammatory response. Findings from the studies suggested the 
significance of the factor of timing in the correction of the immune parameters (Ford, 
1998; Kiecolt-Glaser et al., 2002). The PNI model proposed for this study presents the 
possibility of indentifying predictors for the diseases and an opportunity to focus on 
disease prevention. Chapter 2 will provide detailed discussion regarding the process of 
the physiological stress response initiated by emotions. 
This study used the principles of PNI to investigate the degree to which certain 
diagnosed psychiatric disorders (such as generalized anxiety disorder, posttraumatic 
stress disorder, major depressive disorder, recurrent, and dysthymic disorder) predict the 
development of specific medical diseases (such as atherosclerosis, cardiovascular heart 
disease, rheumatoid arthritis, cancer, and type II diabetes). The statistical methods 
included descriptive cross tabulation, multinomial logistic regression and chi-square test 
for independence to test the psychiatric disorder prediction model that is based on the 
PNI foundation. 
Operational Definitions 
Adrenocorticotropic hormone (ACTH): A hormone which stimulates cortisol 
production from the cortex of the adrenal gland (Kaye & Lightman, 2005). 
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Acute inflammatory response: An initial inflammatory response that occurs to rid 
the body of an infectious agent or remove and repair damaged tissue without the 
activation of the immune system (Rabin, 2005). 
Amino acids: The building blocks and break-down products of proteins (Pinel, 
2003). 
Antibodies: Proteins that bind specifically to antigens on the surface of invading 
microorganisms that promotes the destruction of the microorganism (Pinel, 2003). 
Antigens: Proteins on the surface of cells that identify them as native or foreign 
(Pinel, 2003). 
Atherosclerosis: A chronic inflammatory response to injury in the blood vessels. 
This disorder underlies coronary heart disease and is characterized by a process involving 
inflammation of the lining of blood vessels leading to the progressive accumulation of the 
cellular content flowing in the blood into microscopic lesions in the vessel leading to 
hardening of the vessels and the blockage of blood flow and heart attack (Steptoe & 
Brydon, 2005). 
Autoimmune response: An immune response against one’s own tissue resulting in 
tissue damage (Rabin, 2005). 
Autonomic nervous system (ANS): The part of the peripheral nervous system that 
participates in the regulation of the internal environment of the body (Pinel, 2003). 
Bioimmunoassay: The collection of blood, body fluid, or tissue to assess the 
presence and/or activity of components of the immune system (Dorland’s Medical 
Dictionary, 25th Ed.; Kiecolt-Glaser et al., 2002). 
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Bone resorption: Loss of bone substance by physiological or pathological means 
(Heijnen & Kavelaars, 2005). 
Cancer: Cells within the body that do not respond appropriately to chemical 
messages to stop growing and dividing. The uncontrolled proliferation can result in the 
cellular spreading from the original anatomical location to other regions and organs of the 
body and disrupt normal cellular processes (Walker et al., 2005). 
Cardiovascular heart disease: Partial or complete blockage of the coronary 
arteries resulting in insufficient nutrients and oxygen reaching the heart muscle leading to 
damage of the heart muscle with acute chest pain or sudden death from heart failure 
(Steptoe & Brydon, 2005). 
CD-4: Classified as ‘helper T cells’ because they promote immune reactions 
(Rabin, 2005). 
Cell adhesion molecules (CAMs): Increases the adhesion of cellular debris from 
the blood flow to the vascular walls in the atherosclerosis process (Steptoe & Brydon, 
2005). 
Cognitive-behavioral therapy (CBT): A therapist guided technique of discovery 
of distortions in thinking that lead to error in emotional and/or behavioral responses by an 
individual. The end result of CBT is the reconstruction and re-building of the individual’s 
assumptions (Fleming & Robinson, 2007). 
Comorbid: The presence of additional diseases (disorders) in relation to an index 
disease (disorder) in one individual (Valderas et al., 2009). 
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Corticotrophin releasing factor (CRF): A hormone responsible for promoting the 
synthesis and release of ACTH. It is also has important effects on behavior and cognitive 
processing (Kaye & Lightman, 2005). 
Cortisol: The main effector hormone of the HPA axis that has access to every cell 
in the body and influences many essential stress related cellular processes (Kaye & 
Lightman, 2005). 
 Cytokines: Soluble proteins released primarily from activated immune cells that 
serve as communication signals in cell-to-cell interactions and can influence the activity 
of other cells (Rabin, 2005). 
Dendritic cells: Found in all tissue of the body, these cells have the capability of 
presenting antigens (chemical markers) of invading microorganisms to T lymphocytes in 
preparation for the destruction of the invading microorganism (Rabin, 2005). 
Dysregulation: Disturbance or impairment of normal functioning (Rabin, 2005). 
Dysthymic disorder: A chronically depressed mood that occurs for most of the 
day, more days than not, for at least two years (DSM-IV, 2000). 
Endocrine system: The body organs/glands with the primary function of the 
release of hormones (Pinel, 2003). 
Endothelium cells: Active tissue cells that help to maintain cardiovascular health 
by producing antiplatelet, anticlotting, and other factors to prevent cells from adhering to 
the vascular walls and forming a blockage. The cells also produce nitric oxide that 
maintains the flexible tone of the vascular wall (Steptoe & Brydon, 2005). 
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Epinephrine: A major hormone of the sympathetic nervous system with a role in 
the stress response to influence the liver to increase production of glucose resulting in the 
increase in blood sugar level, increase in breaking down body fats with increase in fatty 
acids in the blood which influences the pancreas to decrease production of insulin. This 
hormone also increases heart contractions with increased blood flow (McCance & 
Huether, 2002). 
Ethnicity: The shared culture and lifestyle of a people (Carter et al. 1996) 
Forgiveness therapy: This therapy approach does not involve reconciliation or 
condoning the experience. It is a process of stopping the mental rehearsal of the wrong, 
recognizing the emotional distress is coming from hurt thoughts, and letting go of the 
painful thoughts (Luskin, 2008). 
Generalized anxiety disorder: This is an anxiety disorder that is not precipitated 
by any obvious event (Pinel, 2003). It is an excessive anxiety or worry that an individual 
finds difficult to control (DSM-IV, 2000, Appendix D). 
Glucocorticoids: Hormones derived from cholesterol that have two major 
functions in the stress response (1) promotes energy conservation and storage by 
regulating glucose and fat uptake during stress-free times (2) primes the immune system 
for a more rapid response to future stress once an initial stress response has occurred. 
Once the stress response is initiated, these hormones suppress and restrain the immune 
system (Kaye & Lightman, 2005) 
Guided imagery and visualization: This is a psychotherapeutic technique 
involving use of the mind to create a sense of physical well-being and health. The 
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clinician uses verbal suggestions to help the patient structure the imagined place of peace 
and calm while exercising control over involuntary functions such as breathing (Ulmann, 
2003). 
Histamine: Hormone that regulates the inflammatory response by the immune 
system (Crouch & McClintic, 1971). 
Homeostasis: The stability of an organism’s constant internal environment (Pinel, 
2003). All of the physiological processes necessary to sustain cell survival and function 
(Kaye & Lightman, 2005). 
Hormones: Chemicals released by specialized cells of the endocrine system into 
the bloodstream that influence the activity and function of target cells and organs. The 
primary functions of these chemicals include reproduction, growth and development, 
energy storage and utilization, and maintenance of physiological equilibrium (Kaye & 
Lightman, 2005). 
Hypothalamus-pituitary-adrenal axis (HPA Axis): The early general alarm 
physiological reaction to stress with the increased production and release of hormones to 
re-direct body systems to prepare for increased energy, defense, and healing from injury 
(Rabin, 2005). 
Immune system: A variety of interactive cells and soluble molecules that patrol 
the blood and tissues to detect the presence of substances/antigens that are foreign to the 
body that can produce illness and destroys and removes the foreign material from the 
body (Rabin, 2005). 
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Immune-challenge: In an experimental design, the presentations of a controlled 
amount of a pathogen, allergen, or wound puncture to assess the immune response 
(Kiecolt-Glaser et al. 2002). 
Immunoglobulin A (IgA): An immune molecule found in external secretions of the 
body and has a protective role to interfere with the ability of microorganisms to enter the 
external body cavities or penetrate tissue (Rabin, 2005).  
Innate immune system: The immune process that is always active monitoring the 
body for the presence of infectious agents and destroys and removes the agents from the 
body (Rabin, 2005). 
Macrophage: Specialized immune cells that seek out, engulf, and consume 
foreign microorganisms that invade the body. Macrophages also remove debris from the 
body (Pinel, 2003). 
Major depression disorder: A depressive disorder characterized by one or more 
major depressive episodes without a history of manic, mixed, or hypomanic episodes that 
are not related to the effects of substance use, medications, or other psychiatric disorders. 
This disorder is associated with a high mortality rate with up to 15% of individuals with 
this diagnosis dying from suicide. This disorder may be preceded by dysthymic disorder 
(DSM-IV, 2000). 
Neuroendocrinology: The study of interactions between the nervous system and 
the endocrine system. 
Neutrophil adherence: Immune cells that bind to foreign particles in the body, 
such as bacteria and kill them by ingesting them (Rabin, 2005). 
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NK cells: A classification of immune cell that reacts to malignant cells and cells 
that are infected with virus to destroy those cells (Rabin, 2005). 
Norepinephrine: The principle hormone/neurotransmitter of the sympathetic 
nervous system (Rabin, 2005). In the stress response it has the following physiological 
influence decreases the immune function, pupil dilation, decreased gastric secretion, 
dilation of blood vessels, dilation of bronchi, vasoconstriction of smooth muscle, 
increased blood pressure, and decrease in digestion (McCance & Huether, 2002). 
Parasympathetic nervous system: Has effects opposite of the sympathetic nervous 
system and is associated with the autonomic nervous system at rest. There is an on-going 
dynamic interaction between the two systems to maintain a state of balance between 
alertness and rest (Rabin, 2005). 
Posttraumatic stress disorder: An individual’s response to a stressor that involves 
intense fear, helplessness, or horror. There is physiological reactivity on exposure to cues 
and the symptoms cause clinically significant distress or impairment (DSM-IV, 2000, 
Appendix D). 
Pro-inflammatory cytokines: Soluble proteins that activate and mediate the 
inflammatory response of the immune system (Rabin, 2005). 
Psychiatric and medical comorbidity: The presence of one or more index 
psychiatric disorders plus the relational presence of one or more medical diseases in a 
single individual (Valderas et al., 2009). 
Psychoneuroimmunology: The study of the relation of stress, emotions, 
immunological dysfunction (especially autoimmunity), and disease, both physical and 
19 
 
 
  
mental; immunological disturbance in conjunction with mental illness (Solomon & Moos, 
1964). 
Psychopharmacology: The manipulation of neural activity and behavior with 
drugs (Pinel, 2006) 
Pulsatile hormone release: The typical pattern of hormone release that occurs in 
large surges several times a day (Pinel, 2003). 
Race: A hereditary category of a person and it involves the passing along of genes 
through reproduction (Carter et al. 1996) 
Rheumatoid arthritis: A chronic inflammatory disease of the joints characterized 
by pain, decreased mobility and stiffness (Heijnen & Kavelaars, 2005). 
Sympatho-adrenomedullary axis (SAM axis): Responsible for the physio-
behavioral ‘fight or flight’ response to perceived danger i.e. cold sweat, muscle tensing, 
change in breathing (Rabin, 2005). 
Sympathetic nervous system: Division of the autonomic nervous system with a 
significant role in the stress response (Rabin, 2005). 
Synovium: Tissue lining of the joints (Heijnen & Kavelaars, 2005). 
T-lymphocytes: Immune cells that mature in the thymus and are then excreted into 
the bloodstream and tissue. These cells are involved ‘cell-mediated immunity’ in ridding 
the body of foreign cells. T-cells that react against an individual’s own tissue are 
eliminated in the thymus as are the T cells that are functionally useless (Rabin, 2005). 
Type II diabetes: This disease is comprised of a heterogenous group of conditions 
in which the insulin secretion is not absolutely compromised (Surwit & Schneider, 1993). 
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Assumptions and Limitations 
Assumptions of the Study 
The PNI model is predicated upon several assumptions. The first is an assumption 
of a direct relationship between emotion and physiological processes that have been 
identified by the PNI model (Kaye & Lightman, 2005; Kiecolt-Glaser, 2002; Rabin, 
2005). PNI research provides support for the assumption that anxiety and depression are 
the most prominent emotional conditions to initiate the hormonal physiological process 
which leads to the acute inflammatory response. The acute inflammatory response is the 
basis of the inflammatory immune diseases addressed in this study (Baumeister et al., 
2003; Kiecolt-Glaser, 2002). There is also the assumption that comorbid psychiatric and 
medical conditions can occur in the absence of biological and hereditary influences 
(Bremner, 2002). In this study, the researcher investigated this assumption by including 
family history for the psychiatric and medical conditions among the independent 
variables. 
As reported by previous researchers of psychiatric and medical disease 
comorbidity, there is the assumption that an archival design will provide cost effective 
and efficient access to a large participant sample (Baumeister, 2003; Moussavi, 2007). 
There is the assumption that the archival approach lacks the opportunity to gather 
information regarding the feelings and perspectives of the individual participants beyond 
what is in the existing document, as compared to other research designs, such as survey 
methods or qualitative data collect methods (Moussavi al., 2007). 
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Limitations of the Study 
 There were several factors related to this study that may limit the generalizability 
of the findings. First, the sampling was limited to a single healthcare system located in 
Michigan. The demographic composition of Michigan, which is located in the 
northeastern region of the United States, may not be representative of other regions of the 
country. As an example, the racial composition in Michigan is predominantly European 
American with African Americans as the second highest population racial group. Asian 
Americans comprised less than 3% of the Michigan population. Hispanic Americans 
comprise 4% of the population. Among the 1,209 cases reviewed, 680 were European 
Americans (63%), 351 were African Americans (32%), 11 were Asian Americans, and 8 
were Hispanic Americans. Cumulatively, the Asian American and Hispanic American 
comprised less than 5% of the cases reviewed. There were thirty cases in the ‘other’ 
racial category. In determining whether or not the sample obtained for this study was 
representative of the demographic mix in the State of Michigan, the report by the 2008 
census was used for comparison. The comparison revealed the European Americans were 
underrepresented in this sample. African Americans were overrepresented in the sample. 
Asian Americans and Hispanic Americans were underrepresented in the sample. The 
representativeness of the sample obtained has important implications for interpreting the 
findings, for generalizing conclusions, and for suggesting future research. 
In addition, the use of a single healthcare entity from which sample cases were 
selected may have unique aspects that may not be generalizable to other healthcare 
facilities. There may be unique elements of how this healthcare system manages patient 
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care and those elements may not be in effect in other healthcare systems in the United 
States. The data collection and recording techniques for this facility may also differ from 
what other healthcare systems use.  
Another factor was the study inclusion criteria which limited the cases reviewed 
to adults 21 years of age and older. Comorbid conditions of children and adolescents 
were not included in the study. The age of the individuals whose cases were reviewed 
was predominantly 50 years of age and over. Age may have had a confounding effect on 
the study because of possible age related medical conditions. Finally, the five year 
population cycle for this study may not have been sufficient to detect the presence of the 
psychiatric disorder and medical disease comorbid condition among the cases not 
included in the study. Previous research indicates that there may be as much as a ten 
years lag between the identification of a psychiatric disorder and the later manifestation 
of related inflammatory based medical diseases. Therefore the five year cycle of data 
collection from the healthcare facility may have been too short a period of time to detect 
the connection between a diagnosis of psychiatric disorders and inflammatory based 
medical diseases. 
Significance of the Study 
The significance of this study was to determine whether certain psychiatric 
disorders predict the presence of specific immune based medical diseases. The inclusion 
of psychiatric disorders can improve disease prevention assessment approaches. The 
addition of disease prevention assessment approaches has important implications in 
healthcare given the millions of individuals in the United States and world wide who are 
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diagnosed annually with psychiatric disorders that could potentially result in the 
development of atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, 
and type II diabetes (Baumeister et al., 2007). 
In addition, the design of this study directly addressed some the shortcomings the 
methodological issues cited by Kiecolt-Glaser et al. (2002), Baumeister et al. (2005), and 
Moussavi et al. (2007). These researchers reported that differences in the design of the 
studies that they reviewed, different styles in writing the results, and lack of verification 
of diagnoses were problematic in terms of generalizing the findings from the studies to 
other samples. The researchers also reported the need for demographic data to better 
understand how demographic variables impacted prediction of the progression of the 
medical disease. The data in this study was obtained from the electronic medical record 
data base of a healthcare system that has uniform information collection protocols. In 
addition, each case included in this study had a clearly identified psychiatric and medical 
diagnosis and contained pre-clinical and family history information. This study included 
demographic variables to address the shortcomings and methodological issues reported 
by previous researchers. 
Professional Application of Results 
The findings of this study could have immediate application by psychiatrists and 
physicians who diagnosis one of the identified psychiatric disorders, especially major 
depression recurrent or generalized anxiety disorder, in their patients. Those diagnoses 
should prompt additional actions such as screening for changes in the bio-immune 
markers for inflammatory conditions and the screening for the inflammatory based 
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medical disorders of atherosclerosis, cardiovascular heart disease, and cancer. The results 
of this study may also prompt the use of psychotherapy techniques which emphasize 
relaxation training for the patient as a part of the initial preventive intervention protocol. 
Psychotherapy and relaxation techniques would help provide patients with skills needed 
to help manage the psychological disorders. In turn the stress reduction techniques could 
help manage the immune inflammatory response which should then decrease the 
likelihood that the associated medical conditions would occur. 
Positive Social Change 
The social issue that this study addressed was the healthcare problem of 
psychiatric and medical disease comorbidity and the need to develop additional disease 
prevention assessment approaches. The health and quality of life for millions of 
individuals in the United States and world wide can be improved with the improvement 
of disease prevention assessments (Spiegel, 2003). Results from this study could be used 
to promote social change by contributing information regarding the relationship between 
the comorbid psychiatric disorders and the inflammatory based medical conditions 
investigated in the study. Professionals could use the information to develop assessment 
plans that identify individuals with psychiatric conditions that are related to the comorbid 
medical diseases. Professionals could then develop prevention programs that minimize 
the subsequent development of the inflammatory diseases. The comprehensive prevention 
plans could encompass periodic screening for the onset of the inflammatory diseases, 
education related to the prognosis of the psychiatric disorders, as well as stress 
management techniques to manage stress associated with the psychiatric disorders. The 
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overall intent of the prevention plans would be to implement preventative measures that 
interrupt or prevent the acute inflammatory response that precipitates the onset of the 
medical diseases. 
Summary 
This chapter provided an introduction to the study that included a presentation of 
the problem statement, research questions, theoretical framework of the study, 
operational definitions, and the assumptions and limitations of the study. This chapter 
concluded with a discussion of the knowledge generated by the study, the professional 
application of the new information, the significance of the study, and the positive social 
change that can occur as a result of the study. Chapter 2 will cover an in depth review of 
the literature related to the theoretical foundation and specific variables of this study. 
Chapter 3 will discuss the research design and approach, including a description of the 
cases included in the sample and determination of the sample size, materials used for the 
study, data collection procedures and the statistical methods selected to analyze the data, 
statement of the hypotheses, and participant protections and rights. Chapter 4 will provide 
a discussion the research findings. Chapter 5 will give a brief over view of the purpose of 
the study, the findings, the implication of the study for positive social change, 
recommendations for action, and recommendations for further studies. 
Chapter 2: Literature Review 
Introduction 
Atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and 
type II diabetes affect millions of individuals throughout the United States and worldwide 
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(Pearson, 2007; Pickup & Crook, 1998). The intent of this research was to determine if 
there was a predictive relationship between those medical diseases and the psychiatric 
disorders of generalized anxiety disorder, posttraumatic stress disorder, major depression 
recurrent, and dysthymic disorder. Research in the field of psychoneuroimmunology 
(PNI) supports the possibility that the psychiatric conditions of depression and anxiety in 
fact may predict onset of atherosclerosis, cardiovascular heart disease, rheumatoid 
arthritis, cancer and type II diabetes (Ford, 1998; Kiecolt-Glaser, 2002). 
During the literature review, the researcher accessed peer reviewed journals and 
articles and academic publications as the information source for related articles. The 
journal articles were found at Sladen Library, which is an affiliate of Wayne State 
University Medical School and Henry Ford Healthcare System, EBSCO database and 
electronic library, and the web-based Google Scholar. The materials were downloaded 
electronically when journal full text was available. The selection of the medical diseases 
for this study was based on the published research findings that indicate a connection 
between the emotional state of prolonged anxiety and/or depression and the development 
of the inflammatory-based disease conditions of atherosclerosis, cardiovascular heart 
disease, rheumatoid arthritis, cancer, and type II diabetes (Heijnen & Kavelaars, 2005; 
Pickup, 2003; Steptoe & Brydon, 2005; Walker & Sharpe, 2005). 
To examine literature that supports the proposed model of psychiatric conditions 
being predictors for certain medical conditions, this chapter presents the following 
sections: The Prevalence and Societal Impact of the medical conditions of 
atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and type II 
27 
 
 
  
diabetes; Psychiatric and Medical Comorbidity, Theoretical Foundation of 
Psychoneuroimmunology; Current Status of PNI Research, PNI as a Potential Mediator 
between Psychiatric and Medical Conditions; description of the PNI Process for the onset 
of Medical Disease Variables; PNI Research Using Psychotherapy; the Proposed PNI 
Model of this Study, Review of Research Methodologies, and Biological Variables of 
Possible Influence. The chapter will conclude with a summary and introduction to 
chapter 3 that describes the methodology used for this study. 
Prevalence and Societal Impact of the Medical and Psychiatric Conditions 
Statistically, prevalence studies have revealed that 12.5 million Americans are 
diagnosed with atherosclerosis and cardiovascular heart disease, and that number could 
double by the year 2050 (Pearson, 2007). Pearson also reported there is an estimated 10 
year period of time between the asymptomatic stage of the diseases to the progressive 
damage to the blood vessel walls that may lead to heart attack or stroke. There are 
550,000 people diagnosed with heart failure each year in the United States (Weisfeldt et 
al., 2007). In 2006 the World Congress of Cardiologists reported that 17.5 million deaths 
occurred worldwide in the year 2005 because of heart attack and stroke. Project Hope 
(2007) reported that medical science has not revealed or developed strategies for 
preventing cardiovascular disease, rather they have only been successful in developing 
strategies for making it less lethal. Heijnen and Kavelaars (2005) reported 68 million 
individuals world-wide suffer from the debilitating disease of rheumatoid arthritis. There 
are 500,000 people who die from cancer each year (University of Rochester, 2007). 
Pickup and Crook (1998) reported 100 million people around the world are diagnosed 
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with type II diabetes. In addition to the human suffering from these diseases, these 
medical conditions have resulted in a $400 billion a year financial burden to individuals 
and society through spending on healthcare and loss of productivity at jobs (Mensah & 
Brown, 2007). There is a pressing need for increased knowledge of the factors that are 
related to the development of atherosclerosis, cardiovascular heart disease, rheumatoid 
arthritis, cancer, and type II diabetes because of the heavy human burden of these 
diseases (Spiegel, 2003).The psychiatric conditions of anxiety and depression also have a 
significant impact on the perceived quality of life as well as being factors in the initiation 
of disease development (Baumeister et al., 2005). In this study there are two psychiatric 
categories; anxiety and depression. Anxiety is subdivided into the clinical diagnoses of 
generalized anxiety disorder and posttraumatic stress disorder. The psychiatric diagnostic 
category of depression is subdivided into major depression recurrent and dysthymic 
disorder. Generalized anxiety disorder includes the clinical features of prolonged 
excessive anxiety and worry. Generalized anxiety disorder affects five percent of the 307 
million people living in the United States (DSM-IV, 2000). Posttraumatic stress disorder 
(PTSD) involves feelings of intense fear and helplessness long after a traumatic 
experience has occurred (DSM-IV, 2000). Bremner (2002) reported approximately 40 
million individuals living in the United States suffer from PTSD. 
The DSM-IV reports major depression recurrent affects 10% to 25% of the female 
population in the U.S. and 5% to 12% of males. Dysthymic disorder, which also involves 
chronic depressed mood, occurs in approximately 6% of the United States population 
(DSM-IV). Moussavi et al. (2007) predicted that by the year 2020 depression will be 
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second only to heart disease as the leading health burden. Moussavi and his colleagues 
also reported that depression is a global public health issue. 
Baumeister et al. (2005) found that people suffering from psychiatric disorder and 
medical disease comorbidity has now become the rule rather than the exception in 
healthcare. These prevalence reports suggest the need for research assessing the 
psychological predictors of the presence of disease for the purpose of developing 
prevention assessment and intervention options. 
Psychiatric and medical comorbidity. Comorbidity refers to the co-existence of 
two or more disease conditions within the same individual (Baumeister et al., 2005). This 
study focused on psychiatric disorder and medical disease comorbidity. In this study, the 
psychiatric conditions were generalized anxiety disorder, posttraumatic stress disorder, 
major depression recurrent, and dysthymic disorder. The medical diseases were 
atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and type II 
diabetes. These diseases were selected because of the established PNI foundation for the 
development of immune based inflammatory diseases. There is also a high representation 
of these conditions in comorbid cases. Baumeister et al. (2005) reported anxiety and 
depression were the most consistent correlates associated with comorbid psychiatric and 
medical pairs. Moussavi and his colleagues conducted a World Health survey in which 
data was obtained from 245,404 adult participants from 60 countries from all regions of 
the world (Moussavi et al., 2007). The results revealed that depression was a comorbid 
condition often presented with medical diseases such as angina, arthritis, asthma, and 
diabetes.  
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In addition to depression, anxiety is prevalent in comorbid cases. In a review of 
45 studies published between 1998 and 2002, Baumeister found that 70.3% of the reports 
were from individuals reporting anxiety in addition to depression in medical comorbid 
conditions. Depression and anxiety paired with medical disease were the most significant 
factors in their perceived diminished quality of life (Baumeister et al., 2005). Kiecolt-
Glaser (1997) also found that the psychiatric disorders of generalized anxiety disorder, 
posttraumatic stress disorder, and major depression recurrent frequently coexisted with 
medical conditions such as atherosclerosis, cardiovascular heart disease, rheumatoid 
arthritis, cancer, and type II diabetes. 
Findings from the aforementioned studies (Baumeister et al., 2005; Kiecolt-
Glaser, 1997; Moussavi et al., 2007) suggest that there is a relationship between certain 
psychiatric disorders and certain medical diseases. The field of psychoneuroimmunology 
provides a foundation for understanding the connection between these psychiatric 
disorders and the medical diseases. 
Theoretical Framework of Psychoneuroimmunology 
Historical overview of PNI. Psychoneuroimmunology (PNI) is the multi-
disciplinary, scientific investigation of the phenomenon of the emotion triggered 
physiological response of the immune system, via hormones released by the endocrine 
system, which frequently results in the development of medical disorders (Pinel, 2006). 
PNI studies have identified the hormones norepinephrine, epinephrine, and cortisol to be 
central to this process. Cortisol, in particular, has the triaging effect during times of 
emotional distress. In this triaging process, cortisol causes the dysregulation of certain 
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cellular and bodily function to give priority to physiological functions that are directly 
related to immediate survival needs, such as increased energy for escape. The immune 
system is not considered to be a priority function, and it is dysregulated. If the emotional 
distress is related to a real physical threat, the system returns to normal upon the 
resolution of the threat. If the distress is prolonged, as with the psychiatric disorders of 
depression and anxiety, the dysregulation is prolonged resulting in cellular damage, 
immune dysfunction, and the possibility of disease. The phenomenon of comorbid 
psychiatric and medical disease has been documented by medical science for the last 138 
years. 
In post Civil War America, Da Costa (1871) noted functional arrhythmia of the 
heart among hospitalized war veterans as a response to trauma induced anxiety. He 
named the disorder ‘irritable heart’ to describe the adaptation of physical functioning 
initiated by emotional stimuli. In 1915, physiologist Walter B. Cannon documented the 
emotions of fear and anxiety initiating a sympathetic nervous system response and 
adaptation to stress reflected in a change in physiological functioning. Cannon coined the 
term ‘fight or flight response’ and the term ‘homeostasis’. 
Selye (1936) advanced the initial work of DaCosta and Cannon by documenting 
the involvement of the endocrine system in the release of hormones during the condition 
of prolonged distress in his animal studies. Selye explored the biological functioning of a 
specific category of hormones central to the acute stress response called glucocorticoids. 
Cortisol was identified as the primary hormone related to stress in the classification of 
glucocorticoids. In 1963, Donald F. Klein extended Selye’s work by using the principles 
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of psychopharmacology as a means of exploring the relationship between panic attacks 
and the physiological adaptation of the stress response. Klein, starting from his discovery 
that imipramine was effective in blocking panic attacks, went on to identify anxiety and 
panic disorder as distinct psychiatric conditions. He discovered that anxiety disorders 
have a biochemical basis. Based on the knowledge gained, Klein developed the 
diagnostic criteria for anxiety disorders. Those criterions remain in current use in the 
DSM. Furthering the investigation of the psychophysiology of stress, George Solomon 
and Rudolf Moos (1963) documented the dysregulation of the immune system as a 
function of the stress response. It was Solomon and Moos who coined the term 
‘psychoimmunology’. Later, Ader and Cohen (1975) demonstrated that the immune 
system could respond to classical conditioning. 
Current Status of Psychoneuroimmunology 
Vale and his colleagues (2001) focused on understanding the corticotrophin 
releasing factor (CRF), which has the central role in initiating the pituitary-adrenal 
response to stress. Pickup et al. (1998), Pickup (2003), and McCance and Huether (2002) 
give the PNI foundation for type II diabetes. 
In 2002 a series of studies were published by Kiecolt-Glaser and her colleagues 
which explored a range of negative emotions and analyzed the relationship between 
negative emotions and the impact on the immune system. The main areas explored by 
Kiecolt-Glaser focused on the effect of anxiety and depression with regard to increased 
susceptibility to infectious diseases and impaired wound healing. Infectious diseases and 
impaired wound healing was the focus for the Kiecolt-Glaser research teams because the 
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immune function in these disorders were more conducive to an experimental design. 
Kiecolt-Glaser et al. wrote infectious pathogens could be controlled, measured by use of 
vaccines, and wound healing studies could be performed by use of biopsy techniques. 
The studies found that the immune system is compromised during times of emotional 
distress. Studies by other researchers related to wound healing also implicated the 
involvement of the inflammatory process of the immune function (Kiecolt-Glaser et al., 
2002; Yang and Glaser, 2005). Recently, more attention has been placed on the acute 
inflammatory response of the immune system in response to prolonged anxiety and 
depression. Part of the acute stress response triggered by anxiety and depression is the 
body’s increased production of proinflammatory molecules called cytokines. The purpose 
of the inflammatory response is to destroy infected or damaged tissue in preparation for 
its removal from the body (Rabin, 2005). This is the normal function of the inflammatory 
response. If however, this process is maintained at a heightened state for a prolonged 
period of time disease processes can start. The next section provides a discussion of those 
diseases. Some of the diseases occurring in response to the acute inflammatory response 
are atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and type II 
diabetes (Heijnen & Kavelaars, 2005; Pickup, 2003; Pickup & Crook, 1998; Steptoe & 
Brydon, 2005; Walker et al., 2005). These were the medical diseases investigated in this 
study. The emotional trigger for the acute inflammatory response investigated in this 
study were the psychiatric conditions of generalized anxiety disorder, posttraumatic stress 
disorder, major depression recurrent, and dysthymic disorder. 
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PNI: A Potential Mediator between Psychiatric and Medical Conditions 
The PNI process is currently believed to start with the presence of a real or 
imagined psychological experience of threat to the safety or emotional integrity of the 
individual self (Bremner, 2002). Rabin (2005) writes this psychological experience 
presents in the form of fear, anxiety or depression. In response to the perceived threat the 
hypothalamus releases the corticotrophin releasing factor (CRF), which increases 
activation of the stress hormone response by the endocrine system. The hypothalamus-
pituitary-adrenal axis (HPA) activation leads to the secretion of adrenocorticotropic 
hormone (ACTH). The secretion of ACTH stimulates the adrenal cortex to secrete the 
hormone cortisol (McCance & Huether, 2002; Rabin, 2005). 
Cortisol is a hormone that affects the functioning of the liver resulting in the 
increase of the blood sugar level in the blood and the breakdown of body protein in 
preparation for increased energy output. The catabolism of protein leads to increased 
amino acids in the blood. In response, the blood pressure elevates and the cardiac output 
increases. There is also a triaging of physiological functioning by the increased 
production of cortisol which suppresses the immune system, giving preference to those 
physiological processes necessary for immediate survival. The immunosuppression is 
reflected in a decrease in production of antibodies and the decrease in histamine. 
Histamine is a significant mediator of the inflammatory response that occurs in the 
disease conditions of atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, 
cancer, and type II diabetes (Pickup, 1998; Rabin, 2005).  
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When the release of cortisol activates the HPA, the branch of the sympathetic 
nervous system referred to as the sympatho-adrenomedullary axis (SAM axis) is also 
activated. The SAM axis is responsible for increased secretion of the hormones 
norepinephrine and epinephrine. These hormones are responsible for the physiological 
response of rapid breathing, trembling, hypervigilance, and redirection of blood flow to 
essential organs during times of acute stress. These were the physiological changes 
documented by Cannon when he used the term ‘fight or flight’ (Cannon, 1915; Kaye & 
Lightman, 2005). 
Figure 2 depicts the PNI model as it pertains to the relationships between 
variables of interest in this study. As indicated in the drawing, the model proposes that 
the psychiatric conditions induce the stress response, which in turn initiates the release of 
the stress hormones that result in the decrease in histamine. Release of the stress 
hormones initiates the inflammatory response of the immune system by increasing the 
release of proinflammatory molecules. This process then leads to the development of the 
medical disease condition. 
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Figure 2.  Diagram of the Acute Inflammatory Response: 
 
All of the medical disease variables in the model for this study have a common 
etiology of being emotionally induced through the increased activation of the sympathetic 
nervous system, and the heightened endocrine response of increased cortisol, 
norepinephrine, and epinephrine which results in the dysregulation of the of the immune 
system (Rabin, 2005). It is theorized that the inflammatory response is related to the 
development of the medical diseases in the proposed study (Steptoe & Brydon, 2005). 
Indeed, Rabin writes that one of the reactions of the immune system’s inflammatory 
response to anxiety or depression is the increased production of proinflammatory 
cytokines that further perpetuates the inflammatory response. As reported earlier, the 
basic function of the inflammatory response in the body is to destroy damaged, diseased, 
or infected cells in preparation for removal from the body (Rabin, 2005). 
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PNI Process for the Medical Diseases 
The acute inflammatory response to prolonged psychological states of anxiety or 
depression is described by the PNI model as the basis of the diseases of atherosclerosis, 
cardiovascular heart disease, rheumatoid arthritis, cancer, and type II diabetes. A 
discussion of these processes follows: 
Atherosclerosis: Atherosclerosis is an inflammatory response in the vascular 
system. The sympathetic nervous system triggers the endocrine system to release 
hormones that re-direct T-lymphocytes, monocytes, and proinflammatory cytokines to 
the blood vessels to initiate the wound healing process in response to the microscopic 
lesion injuries to the endothelium cell lining of the blood vessel walls. The lesions are 
caused by the shearing effect of high blood pressure. The presence of cortisol, however 
results in a dysfunction of the endothelial cells. The cells are designed to produce 
antiplatelet, anticlotting, and fibrinolytic factors to prevent cellular matter passing in the 
blood stream from adhering to the blood vessel walls and creating a blockage. The 
functional alteration of the endothelium cells by cortisol allows low-density lipoproteins 
(LDL) to adhere to the vessel walls and migrate into the lesion areas. When exposed to 
the oxygenated blood within the vascular wall, the LDL undergoes oxidation forming 
free radicals that further damage the vessel lining leading to reduced elasticity and 
hardening of the vessels. Eventually there is blockage leading to heart attack or stroke 
(Steptoe & Brydon, 2005). 
Cardiovascular heart disease: The PNI process for the development of 
cardiovascular heart disease (CVD) is similar to that of atherosclerosis in that a 
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functional impairment of the endothelium cells lining the interior walls of the blood 
vessels occurs. In CVD however, it is the impairment of the endothelial cells that result in 
the recruitment of and adhesion of monocytes, T-lymphocytes, and platelets to the 
vulnerable curving areas of the vessel. Cell adhesion molecules (CAMs) mediate the 
adhesion process when they are up-regulated by the endothelium cells. The pro-
inflammatory cytokines on the endothelium wall also attract the adhesion molecules. At 
the same time macrophages that have the immune function of ingesting and removing 
cellular debris, promote the atherosclerosis process by producing cytokines and growth 
factors. These factors aid in the oxidation of LDL-cholesterol and transporting those 
toxins through the blood vessels that further damages the arterial vessels. When an 
obstruction occurs in the vessel, there is a decrease in the blood flow that provides 
nutrients and oxygen to the heart thus resulting in cell damage. As heart muscle cells 
become damaged, the inflammatory response destroys the damaged cells, thus 
perpetuating heart damage (Steptoe & Brydon, 2005). 
Rheumatoid arthritis: Rheumatoid arthritis results from the dysregulation of the 
immune system by the increased activation of the (HPA) axis which involves the over 
production of cortisol. The impaired immune system develops an autoimmune response 
resulting from the dysregulation of the immune system by cortisol. In this response, the 
host immune system reacts to its own antigens and initiates an inflammatory response 
that destroys the synovium cells that comprise the tissue lining the joints. With the 
destruction of the synovium there is eventual erosion of the joint cartilage, which results 
in the pain of bone rubbing against bone. Finally, bone resorption occurs, which is the 
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loss of bone substance. The loss of bone leads to joint deformities associated with 
rheumatoid arthritis (Heijnen & Kavelaars, 2005). 
Cancer: Cancer results from the combination of suppression of the immune 
system caused by excess cortisol and the impaired ability of the immune system to detect 
and destroy mutations of host cells that form tumors. In this condition the inflammatory 
response is not effective in detecting and destroying mutated cells. The effect of the 
impaired immune response is compounded by the decreased production of NK cells, T-
lymphocyte cells, dendritic cells, and antibodies that have anti-cancer properties (Walker 
et al., 2005). 
Type II diabetes: Type II diabetes is a response of the innate immune system 
mediated by the hypothalamic-pituitary-adrenal (HPA) axis. During the stress response, 
proinflammatory cytokines that are released by macrophages act on the brain to release 
corticotrophin-releasing factor (CRF) from the hypothalamus. The CRF initiates an 
increased production of stress hormones, including cortisol, which suppresses the 
immune system. Cortisol, with norepinephrine and epinephrine influences the liver to 
increase insulin resistance to optimize blood sugar levels available for immediate energy 
output. In the chronic anxiety or depressive state, the on-going condition of 
hyperglycemia and dysregulation of the immune system can result in the impairment of 
the insulin secretion by the beta cells of the pancreas, which is the basis for the 
development of type II diabetes (Pickup, 2003). 
Medical science is in the forefront in the treatment of these diseases once the 
disease process has been initiated. Studies involving psychotherapy to enhance immune 
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function to resist disease development, is also substantial. The next section will explore 
the evidence-based support for psychotherapy in lessening the effects of PNI based 
medical conditions. 
PNI Research Using Psychotherapy 
Research in PNI suggests a role for psychotherapy as a preventative or 
ameliorating intervention for some PNI related disease process. Kiecolt-Glaser et al. 
(1985) were among the first researchers to conduct studies of the effect of behavioral 
interventions on the immune system. They investigated the meditating effect of relaxation 
and guided imagery on healthy young and healthy older adults exposed to a vaccine as an 
immune-challenge. Kiecolt-Glaser and her team found a positive result of a 30% increase 
in NK cell count in response to a month of relaxation training. In a later study, Kiecolt-
Glaser, Glaser, and Strain (1986) investigated the effect of relaxation training on healthy 
medical students. They found increases in the CD-4 cell count of the students. CD-4 is a 
complement component on an antibody that helps the antibody to adhere to a bacteria or 
other pathogen to allow the antibody to destroy it (Rabin, 2005). Subsequent archival 
studies by Kiecolt-Glaser (1992) regarding the association between psychiatric and 
medical conditions concluded there is an enhancement of the immune function with the 
use of psychological interventions, such as relaxation, hypnosis, self-disclosure, and 
cognitive-behavioral therapy. 
It remained unclear, however, precisely how the above referenced enhancements 
to the immune function translated into discernible health improvements, such as altering 
the development of the disease or the severity and duration of the disease. What still had 
41 
 
 
  
not been explored was the use of these techniques to prevent the development of disease. 
Colbert (2006) presented the position that the goal of psychotherapy is to move the 
individual from sympathetic nervous system (SNS) dominance to parasympathetic 
nervous system (PNS) dominance. Figure 3 is a visual depiction of Colbert’s proposition 
of the goals of psychotherapy with regard to emotional distress. 
 
 
Figure 3.  Diagram Depicting Colbert’s Physiological Goal of Psychotherapy 
 
PNI Studies linking Psychotherapy to Immune Function 
PNI research conducted to study the immune response to psychotherapy has 
yielded mixed results. There have been a number of studies applying various forms of 
relaxation techniques, trauma disclosure, and cognitive-behavioral therapy (CBT) 
interventions to measure change in immune function. Some of the studies were specific to 
a disease processes while others were designed to assess the status of immune markers. 
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As an example, Kraaimaat, Brons, Geenen, and Bijlsma (1995) studied patients with 
rheumatoid arthritis using cognitive-behavioral therapy. The participants in the study 
were divided into three groups; CBT treatment, occupational therapy, and the control 
group comprised of patients on the wait-list. The CBT group received 10 sessions that 
included progressive relaxation, rational thinking, and instruction on strategies for coping 
with pain. The study found no therapeutic effect on the health status of the CBT group. 
The laboratory measures of disease activity revealed progressive deterioration actually 
continued during the treatment for all of the groups. 
Conversely, Witvliet, Ludwig, and Vander Laas (2001) studied forgiveness 
therapy based on the supposition that responses that victims develop toward their 
offenders not only affects their cognition but also impacts their emotional and physical 
health. Witvliet and colleagues studied 71 participants; 35 females and 36 males. The 
researchers found that forgiving thoughts prompted a greater sense of control and 
decreased the physiological stress response as measured by electromyogram, skin 
conductance, blood pressure, and heart rate, all of which reflect the transition from 
sympathetic nervous system dominance to the parasympathetic nervous system 
dominance, as posited by Colbert (2007). 
Petrie, Booth, Pennebaker, Davidson, and Thomas (1995) investigated trauma 
disclosure and its influence on the immune response. In their study forty medical students 
with trauma histories who also tested negative for the hepatitis B antibodies were 
randomly assigned to either a treatment group or control group. The hepatitis B vaccine 
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was used as the immune challenge. The participants in the trauma disclosure group 
showed significantly higher antibody levels against hepatitis B. 
Sherman, Carlson, McCubbing, and Wilson (1997) investigated immune 
enhancement by use of progressive muscle relaxation. In this study 21 participants 
suffering from conditions of chronic pain alternated between relaxation exercises and rest 
for equal periods of time. Salivary secretion of immunoglobulin A was measured in 
addition to level of mood, pain, and tension before and after the exercise. Those patients 
receiving relaxation training had significant increases in immunoglobulin A in the saliva 
specimens. 
Pawlow and Jones (2002) used abbreviated progressive relaxation training 
techniques with 46 participants in the treatment group and 15 participants in the control 
group. The researchers found the brief relaxation exercises led to significantly lower 
levels of heart rate, state anxiety, perceived stress, and salivary cortisol levels reflecting 
improved immune function. Also using relaxation techniques Surwit, McCaskill, Ross, 
and Feingloss (1991) investigated relaxation training with individuals diagnosed with 
Type II diabetes. In the study 38 participants were divided into two groups; group 1 
received relaxation training with diabetes education and group 2 received diabetes 
education alone. Pre/post treatment measures were taken of the metabolic functioning of 
the participants. The treatment program was for eight weeks with two post treatment 
follow-up assessments. In general, relaxation training to significant improvement on any 
of the measures of glycemic control, such as glucose tolerance, glucose fasting level, or 
glycohemoglobin. However, participants who scored high on trait anxiety and 
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neuroticism on the pretest psychological assessment instruments, and showed a large 
initial glycemic response to epinephrine at the pre-treatment stage, showed greater 
improvements in glucose tolerance after relaxation training. 
A number of researchers investigated the use of guided imagery on the 
functioning of the immune system, thus adding a cognitive component to the relaxation 
technique. Cupal, Brewer, and Britton (2001) explored the use of guided imagery plus 
relaxation techniques with 30 participants recovering from knee surgery and experiencing 
re-injury anxiety. The treatment group displayed greater knee strength and decrease in re-
injury anxiety and pain compared to the control group. Gruber, Hall, and Hersh (1988) 
studied relaxation and guided imagery therapy with female cancer patients. Serum blood 
samples revealed that immune cell function increased. In a later study, Gruber, Hersh, 
Hall, Waletzky, Kunz, and Weiss (1993) conducted an 18 month study of cancer patients 
using guided imagery and relaxation. The results revealed an increase in NK cell activity 
and lymphocyte responsiveness. Donaldson (2000) used mental visualization on 20 
medical students who had an infectious disease diagnosis. The researchers reported white 
blood cell counts were significantly increased in the treatment group. Hall, Papas, Tosi, 
and Olness (1996) researched the efficacy of mental imagery techniques on enhancing 
immune function. The research began with the hypothesis that mental imagery would 
augment the effect of relaxation techniques. The immune function the researchers used 
was neutrophil adherence. The neutrophil immune cell is necessary for the destruction of 
organisms, such as disease bearing bacteria that invade the body. Adherence to the 
foreign organism is vital for the destructive process. This study involved fifteen 
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participants. The researchers found the reverse of what they expected. The group that had 
relaxation techniques alone had a greater increase in neutrophil adherence compared to 
the group involved in the cognitive process of guided imagery and relaxation training. 
The use of conversational psychotherapy and its effect on the immune system was 
explored by Van der Pompe, Dulvenvoorden, Antoni, Visser, and Heijnen (1997). In a 
short-term, 13 week group psychotherapy treatment with women diagnosed with breast 
cancer, the researchers assessed the response of the immune system. Van der Pompe et al. 
found lower levels of plasma cortisol among other improved immune markers in the 
treatment group. It was noted that the improvement was only found in individuals who 
already had relatively high endocrine and immune baseline levels. In another study 
involving the effect of cognitive-hypnotic techniques on skin reactivity to histamine, 
Laidlaw, Booth, and Large (1996) investigated the acute inflammatory response of the 
immune system. Thirty-eight participants were involved in the study. The researchers 
found 32 of the 38 participants had a significant decrease in weal size as a result of the 
therapy treatment. A weal is a skin reaction to an allergen characterized by red, raised 
areas on the skin. This study assessed this reaction to investigate the histamine function 
of the immune system. Histamine is a major hormone that modulates the production of 
proinflammatory cytokines. They noted that feelings of irritability, tension, and high 
blood pressure readings were associated with less weal size change. Those participants 
who were peaceful and had lower blood pressure readings had a smaller weal 
inflammatory response. 
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In another study involving the inflammatory response, Lutgendorf et al. (2000) 
recruited 50 participants, 28 males and 22 females who were pre-trained in relaxation 
using an imagery-based relaxation tape. The researchers used capsaicin as the immune 
challenge. Capsaicin is an active ingredient in chili peppers. Lutgendorf and his 
colleagues found a significantly smaller flare response among the relaxation treatment 
group. 
Several observations were made in the review of the research involving the 
application of psychotherapeutic methods to assess its influence on the immune system. 
Psychotherapy that has a direct focus on attaining relaxation appeared most effective at 
affecting the immune response on a consistent basis. The influences of the immune 
parameters that underlie many of the medical disease processes are significantly affected. 
The studies also demonstrated that the immune response can be intentionally and 
specifically moderated by psychotherapy. The findings also demonstrated that once the 
disease process had been initiated, modulation of the immune system by psychotherapy 
had no effect on the progression of the disease. These studies indicate that the use of 
intervention techniques, such as psychotherapy, have been shown to have a positive 
impact on the immune system. In turn this improved functioning could be instrumental in 
lessening the likelihood that a person would develop medical diseases related to poor 
functioning of the immune system and the inflammatory response. 
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Influence of Biological and Personal Variables Related to the Inflammatory Based 
Medical Diseases 
In addition to the psychiatric and medical diseases discussed in this chapter, 
previous researchers have identified personal factors such as family history of the 
psychiatric disorder, family history of the medical disorder, gender, and race as important 
to understanding the possible influence of genetic predisposition in the formation of 
comorbid conditions (Baumeister et al., 2005; Kiecolt-Glaser et al. 2002; Moussavi et al., 
2007). Kiecolt-Glaser et al. (2002) also suggested the importance of including chemical 
dependence history in studies of comorbid occurrences of psychiatric and medical 
conditions because of its negative effect on both mental and physical health. Pinel (2006) 
recently reported the prevalence of chemical dependence among individuals suffering 
from comorbid conditions. 
In considering race as a factor related to comorbid psychiatric and medical 
conditions, Cater, Sbrocco, and Carter (1996) clarified the distinction between race and 
ethnicity and the appropriate use of these terms in research. Carter and colleagues defined 
ethnicity as the shared culture and lifestyle of a people. Race relates to the hereditary 
traits of a person that involves the passing along of genes through reproduction. Carter’s 
definition of race was used for this study. The other biological factors that were included 
in the present study were family history of the diagnosed psychiatric disorder and family 
history of the diagnosed medical disorder. 
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The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) report 
familial associations related to the trait of anxiety; but studies regarding the etiology of 
generalized anxiety disorder as an inherited predisposition are not consistent. 
Posttraumatic stress disorder is a condition to which a person can have a genetic 
predisposition for developing when exposed to trauma, but research regarding this is 
similarly inconclusive (Bremner, 2002). The psychiatric category of depression has 
strong support for a genetic link to predispositions for an individual to develop the 
disorder. The DSM-IV reports major depressive disorder is 1.5 to 3 times more common 
among first degree biological relatives. Major depression is also twice as common among 
adult females as males (DSM). The DSM-IV also reports that adult females are two to 
three times more likely to develop dysthymic disorder. Chemical dependence is a factor 
cited in all of the above psychiatric conditions as a factor to be considered when 
conducting a psychiatric assessment because of the direct effect of toxicity or the residual 
effects of drug and/or alcohol addiction on mental health functioning. The chronic 
toxicity from drug and alcohol addiction also has negative physiological effects that 
suppress the immune system (Pinel, 2006). 
When viewing the diseases investigated in this study from the perspective of 
possible hereditary influences, Taylor and colleagues (2005) used a sequential logistic 
model to determine risk factors for the development of atherosclerosis and cardiovascular 
heart disease. The researchers found that male gender and European American descent 
were among the best-fit hereditary markers for prediction of disease development. 
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Hughes et al. (2006) explored genetic factors involved in the development of 
rheumatoid arthritis. Hughes and colleagues found that African Americans carry the 
nucleotide for rheumatoid arthritis more frequently than European Americans. Other 
studies focused on the relationship between family ties and the development of cancer. 
Schlehe and colleagues (2008) studied hereditary factors related to the development of 
breast and ovarian cancer in women. They found a 60% to 80% lifetime risk for the 
development of breast cancer and a 20% to 40% risk for the development of ovarian 
cancer among family members. Wolski and his colleagues (2004) investigated prostate 
cancer and found a 10% higher risk among male family members.  
O’Rahilly, Barroso, and Wareham (2005) investigated gene variants and the 
development of type II diabetes. The researchers concluded there are a few gene variants 
that have been identified as being related but they reported more research is necessary to 
construct the genetic information necessary to be helpful for prevention and treatment. 
Although it was beyond the scope of the present research to address the 
contribution of genetics to the development of psychiatric and medical comorbid 
conditions, it is valuable to assess the frequency of occurrence and relationship of the 
demographic and biological variables on the comorbid pairs that are formed. For this 
reason the present study used the variables of age of the first documented psychiatric 
diagnosis, age of the first documented medical disease diagnosis, gender, race, absence or 
presence of chemical dependence diagnosis, family history of a similar psychiatric 
diagnosis, and family history of a similar medical diagnosis as predictor variables in this 
study. 
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To investigate psychiatric predictors in medical disease comorbidity, an archival 
design was employed for this study. Previous researchers selecting this method have used 
internet searches to access medical databases, reviewed studies published in journals, or 
accessed medical records. The following section will provide a discussion on each of 
these methodological approaches. 
 
Review of Research Methodologies 
The research methodological approaches used to access information about large 
populations are archival research, internet medical website databases, and surveys. 
Archival research has contributed much to our gaining a sense of the larger scheme of the 
process of emotionally induced medical disorders. An example of a quantitative archival 
method was accomplished in a monumental study undertaken by Kiecolt-Glaser and 
colleagues (2002). The review included all of the PNI studies published in the journal 
Psychosomatic since the journal’s inception in 1939 that were related to the criteria for 
the current study. The inclusion criterion was that the studies had to include 
immunoassays that measured the biochemical markers of the immune system. If the study 
was an in vivo study a challenge would had to have been used in the study. A challenge 
refers to controlled exposure to a pathogen such as a vaccine. The research articles also 
had to involve an immune-based disease that was diagnosed prior to the diagnosis of the 
medical illness. After selecting the relevant studies, Kiecolt-Glaser and her team found 
they had accessed 66% of all published research in the PNI field; this included what had 
been published in other similar journals. This study was significant because the 
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researchers attempted to understand the predictive relationship among the psychiatric and 
medical diagnoses. They found that immune function impairment covaried with the 
psychiatric disorders of anxiety and depression. Two major weaknesses were reported by 
the researchers. The first was the lack of demographic and pre-clinical information to 
provide clarity to the interpretation of the findings. The second limitation of the study 
was the broad range of research methods used among the different individual studies that 
were accessed (Kiecolt-Glaser et al., 2002). 
Baumeister, Kalke, and Harter (2005) provided an example of a quantitative 
internet research method. The researchers conducted an internet-based search using the 
Medline website. The researchers accessed all of the English and German language 
literature published up to 2002 on studies involving psychiatric and medical disease 
comorbidity. The inclusion criterion used by Baumeister and his colleagues for including 
an article in their study were that the study had to be empirical in nature, the participants 
had to be 21 years old or older, and the participants had to have one of the six targeted 
medical diseases. The researchers found 481 studies, but after further screening 45 
studies were accepted for the study. The authors did not discuss the number of cases 
required to meet statistical power in their study. In discussing the strengths and 
weaknesses of the methodology used, Baumeister et al. reported several factors that 
limited the generalizability of their findings. First that database was too small to draw 
conclusions about specific populations. Second, the heterogeneous methods used by the 
different original researchers made simple summaries of the findings very difficult, and 
some of the studies used the patient’s self report for medical comorbidities, which led to 
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questionable validity of the results. In addition, when psychiatric comorbidity was 
assessed, some of the studies used screening instruments, which did not provide a definite 
psychiatric diagnosis. 
Wells, Rogers, Burnam, Greenfield, and Ware (1991) utilized a parallel archival 
research method with a purposive sampling approach. Wells et al. accessed the clinical 
records of 1,152 adults in outpatient treatment programs. The researchers also included 
survey interviews of the participants that were conducted by trained clinicians. The focus 
of the study was psychiatric and medical comorbidity. The patients in their study were 
diagnosed with depression as the psychiatric disorder. The medical conditions included 
coronary artery disease, hypertension, diabetes, gastrointestinal disorder, chronic back 
problems, chronic lung problems, angina, and arthritis. The researchers noted difficulty 
with the survey component of the study because of the side-effects of the psychiatric 
medication with some of the patients. The researchers found that patients with clinical 
depression had significantly higher occurrences of hypertension and arthritis than non-
depressed patients (Wells et al., 1991). 
Boscarino (1997) conducted an archival study investigating the occurrence of 
posttraumatic stress disorder among individuals exposed to severe stress, their rate of 
medical problems and their use of the medical system. Boscarino reviewed the medical 
histories of 1,399 male Vietnam veterans who had combat exposure. A 20 year time 
period was used with the selection of veterans who entered the military between 1965 and 
1971. An additional participant criterion was that each participant had a pay grade level 
of sergeant or lower. Boscarino also included an interview component and self-report 
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measures with his study. There were some reported difficulties with the self reporting 
assessments. The issue was related to the self report of symptoms and actual diagnoses of 
the participants in the study. Boscarino (1997) found a statistically significant link 
between severe emotional stress exposure that was to the presence of PTSD and medical 
disease. 
Moussavi et al. (2007) used a mixed method survey approach in their research 
design. The focus of the study was the comorbidity of depression with angina, arthritis, 
asthma, or diabetes. The World Health Organization (WHO) sponsored the research but 
the organization was not involved the research design or the interpretation of the data 
obtained. The WHO Survey was used to collect information from 245, 404 individuals 
aged 21 years old or older from 60 different countries. Study participants were drawn 
from 26 European countries, 15 African countries, 6 from the Americas, 4 from the 
eastern Mediterranean, 5 from Southeast Asia, and 4 from the Pacific region. In 
discussing the weaknesses of the study, the researchers cited the possible problem of 
participants from some countries under-reporting depression because of socio-cultural 
factors. The researchers also reported not including questions regarding the onset and 
duration of illness. Despite the limitations noted by the researchers, the major finding of 
the study concluded that depression, in combination with any medical disease results in a 
greater decrement in health when compared to the medical disease alone (Moussavi, 
2007). 
The methodology selected for the present study was a quantitative, parallel 
archival design because it is the most efficient and cost effective among the options 
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explored (Baumeister, 2005). A purposive stratified sampling schema was used. The 
research problem in this study was focused on analyzing the relationship between the 
psychiatric and medical disease comorbid conditions. The perspective of the research 
posited using the psychiatric diagnosis as a predictor of the type of medical disease for 
the comorbid pair. The study also considered some of the biological and pre-clinical 
information documented for each case that could influence disease development. Being 
mindful of barriers and issues reported by other researchers, this study accessed and 
reviewed the electronic medical records of patients treated in a multi-hospital healthcare 
system that has uniformity in patient assessment protocols and full documentation of the 
medical and psychiatric diagnoses and treatment histories. The full research design for 
the present study will be presented in chapter three. 
Summary 
The literature review for this study was generated by accessing peer reviewed 
journals and articles and academic publications information sources. The literature 
reviewed provided support for the PNI model in relation to psychiatric and medical 
disease comorbidity. There was a gap in the literature regarding the investigation of 
psychiatric disorders as predictors of medical diseases. The present study investigated the 
psychiatric disorders of generalized anxiety disorder, posttraumatic stress disorder, major 
depression recurrent, and dysthymic disorder as predictors of the medical diseases that 
result from the inflammatory response of the immune system. The medical diseases 
investigated in this study were atherosclerosis, cardiovascular heart disease, rheumatoid 
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arthritis, cancer, and type II diabetes. The research questions addressed in the present 
study were: 
Question 1: For individuals with comorbid psychiatric disorder and medical disease 
diagnoses, what is the association between the first type of psychiatric diagnosis and the 
first medical diagnosis? 
Question 2: Among individuals with comorbid psychiatric and medical disease 
diagnoses, to what degree does the presence of a psychiatric disorder and the 
demographic variables of gender, race, family psychiatric history, family medical history, 
and chemical dependence history significantly influence the presence of the medical 
disorders atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and 
type II diabetes in the comorbid pairs? 
Question 3: To what degree does the presence of a psychiatric disorder as the first 
diagnosis and the diagnosed psychiatric disorder predict the medical disorders for the 
comorbid pairs included in the study? 
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Chapter 3: Research Method 
Introduction 
Chapter 2 discussed the scientific support for the psychoneuroimmunology (PNI) 
model as that model pertains to the current study. The PNI model was established by 
studies using bioimmunoassays, empirical, and experimental methods. The clinical 
findings of these studies revealed the dysregulation of the immune system that occurs in 
response to emotional conditions (Cannon, 1915; Da Costa, 1871; Kaye & Lightman, 
2005; Kiecolt-Glaser, 1992; Rabin, 2005; Steptoe & Brydon, 2005; Walker et al., 2005). 
The purpose of this study was to determine if certain psychiatric disorders could be used 
to predict the presence of specific inflammatory based immune diseases. The independent 
predictor variables were generalized anxiety disorder, posttraumatic stress disorder, 
major depression recurrent, and dysthymic disorder. The dependent medical disorders 
were atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and type 
II diabetes. 
The present chapter will focus on the methodology used in the current study. The 
topics that will be covered in this chapter include, Research Approach, Archival Research 
Methods, Research Design, Sample Selection, Hypotheses and Analysis, Data Analysis, 
Materials and Instruments, and Participant and Record Confidentiality. The chapter will 
conclude with a summary. 
Archival Research Methods 
An archival methodological scheme was employed as the research methodology 
for this study. As examples of previous research of this type, Kiecolt-Glaser et al. (2002) 
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conducted an archival study of a single journal since the journal’s inception. This 
involved 62 years of published studies in the area of PNI. Kiecolt-Glaser and colleagues 
reported methodological weakness of their study, citing broad heterogeneity in the 
research designs and in the interpretations by the original authors of the studies as being 
limiting factors of their research. The Kiecolt-Glaser study also found a lack of pre-
clinical and biological information that potentially could assist in the interpretation of the 
data to be a limitation of their study. 
Baumeister et al. (2005) conducted an archival study using an internet medical 
database. For the criteria specified in their project the number of cases they could accept 
was too small to draw conclusions about specific populations. Also, as with Keicolt-
Glaser, the researchers found too broad of a difference in the methodologies used by the 
original researchers and the differences in reporting the findings by the original 
researchers was problematic. Baumeister and colleagues also questioned the validity of 
some of the studies because of the reliance on participant self-report for the psychiatric 
and/or medical diagnoses rather than having clinical documentation. 
Wells, Rogers, Burnam, Greenfield, and Ware (1991) and Boscarino (1997) used 
a parallel archival research methodology. The focus of the study was comorbidity among 
depressed patients and how treatment varies across major types of clinical settings. Wells 
and colleagues reported problems with the survey component of their study, which 
required the active participation of the participants. Impaired engagement due to 
medication side-effects was cited. 
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Boscarino (1997) investigated the development of posttraumatic stress disorder 
and medical comorbidity among individuals with exposure to severe stress. Boscarino 
found a weakness of his study to be the self-report component. He reported there were 
issues regarding the self report of symptoms and the diagnoses in a number of the cases. 
In reviewing the methodological approaches used by earlier researchers, it 
appeared that the quantitative archival approach had the greatest benefit for accessing a 
large number of cases while being cost efficient (Boscarino, 1997; Lehrer, 2002; Kiecolt-
Glaser, 2002). There were several benefits of the archival design for this study. The use 
of electronic medical records allowed 24 hours a day access to the documents, rather than 
confining the researcher to the set business hours of medical record departments. This 
study design also eliminated the need for adequate accommodations, such as office space, 
at the various sites. The electronic medical records allowed the researcher access to 
records from a broad geographic area in the State of Michigan without having to travel to 
the sites. The records could be accessed from a single office site, thereby saving the cost 
and time associated with travel. The use of electronic medical records of a large 
healthcare system provided the required clinical documentation of both the psychiatric 
and the medical disease diagnoses. This was the information that was reported as lacking 
by previous researchers. In addition to uniformity in clinical documentation, these 
electronic medical records also contained the pre-clinical and other biological 
information that was identified as important to understanding possible demographic 
influences on psychiatric and medical disease comorbidity development (Kiecolt-Glaser 
et al., 2002). 
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This is an archival quantitative study specifically using information from medical 
records maintained by a multihospital healthcare system. The archival data was originally 
collected in accordance with the standardized documentation protocol of a single 
healthcare system. There were also pre-established confidentiality protections for the 
patients (HFHS Clinical Documentation Policy and Procedures, 1997 revision). 
The archival data from a five year cycle was selected to capture the most current 
health status information in the records reviewed for this study. Wallis, Borgman, 
Mayernik, and Pepe (2008) stated that in general, the life cycle for data in the sciences is 
determined by each stage of a process in which information transitions from one or more 
persons with similar domains of knowledge and training to the next. In clinical settings 
the cycle may be characterized as a patient transitioning from one level of care or phase 
of treatment to another. Wallis et al. reported that in research, only those studies using 
multi-year datasets from a single location have established archival practices for 
maintaining current relevance of their data. The hospital system where this study was 
conducted met the requirements specified by Wallis. 
Lyon (2003) discussed the ‘scholarly knowledge cycle’ with regard to secondary 
information. According to the article, the advent of technology and the ability to store and 
transfer data causes certain fields, medicine for instance, to become data rich for 
quantitative sciences (Lyon, 2003). Lyons wrote that the scholarly knowledge cycle 
extends beyond the concept of information cycles. For this to apply, Lyon wrote, a 
number of assumptions must be satisfied. The assumptions are a) that the integrity of the 
original data is maintained, b) there is a shared understanding of the concept of 
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provenance, c) the original dataset is adequately described using a metadata description 
framework based on agreed standards, d) a common ontology for the domain is 
understood, e) each dataset and derived data and information are uniquely identified, and 
f) there is an open linking technology applied to the original dataset and the derived data 
and information. 
The archival data collected for this study was from a network of eleven major 
hospitals which are administrated under a single corporate body that is connected to a 
shared electronic medical record keeping system. All of the clinical records meeting the 
inclusion criterion for clinically documented psychiatric and medical disease diagnoses 
for this study were drawn from the January 2005 through September 2010 time period. 
Study Variables 
The intent of this study was to determine if certain psychiatric disorders predicted 
the presence of certain medical disorders. The psychiatric disorders, the biological, and 
the demographic factors were the independent/predictor variables. The psychiatric 
disorders were generalized anxiety disorder and posttraumatic stress disorder, major 
depression recurrent, and dysthymic disorder. The medical disorders were the dependent 
variables. The medical disorders were: atherosclerosis, cardiovascular heart disease, 
rheumatoid arthritis, cancer, and type II Diabetes. The biological and demographic 
factors were, age of the first documented psychiatric diagnosis, age of the first 
documented medical disease diagnosis, gender, race, absence or presence of a chemical 
dependence diagnosis, family history of a similar psychiatric diagnosis, and family 
history of a similar medical diagnosis. This study also analyzed the whether the 
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biological and demographic variables were related to the types of co-morbid pairs in the 
study.  
To test the hypotheses for the research questions, data analyses consisted of 
descriptive cross tabulation to describe the observed frequencies of the personal and 
biological characteristics of cases included in the study, the chi-square tests of 
independence were used to analyze the patterns of the comorbid pairings, and 
multinomial logistic regression was used to determine the degree to which the 
independent variables (psychiatric disorders, biological factors, and demographic 
variables) predicted the type of medical disease. 
Setting and Sample Selection 
The source for the clinical cases in this study was the electronic medical records 
of adult patients treated in the Behavioral Services Division of a healthcare system 
comprised of a network of hospitals and clinics located in southeastern Michigan. As a 
member of the clinical staff this researcher had the training and security clearance to 
access the identified cases within the secured database website which housed the data. 
The initial identification of the cases was made by the designated Institutional Review 
Board (IRB) manager of the electronic medical records. The ICD-9 codes for the medical 
diseases and the DSM-IV codes for the psychiatric disorders were used to conduct the 
data base search of the records meeting the inclusion criterion. The specific criterion was 
that all of the cases must have at least one of the designated psychiatric diagnoses plus at 
least one of the designated medical disease diagnoses (Valderas et al., 2009). A minimum 
of 632 cases were required to meet the sample size recommended by Hsieh, Bloch, and 
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Larsen (1998). There was an increase in the sample size, as suggested by Demidenko 
(2008) to accommodate the possible loss of cases because of missing data. The sample 
size minimum was increased to 800 cases. A five year archival data population provided 
the source for the cases included in this study (Lyon, 2003; Wallis et al, 2008). 
Achieving cultural diversity was a consideration for the cases sampled in this 
study. Cultural diversity was presumed in this study by selecting cases from the various 
hospital and clinic locations in the State of Michigan with naturally occurring population 
differences. The healthcare system consists of eleven major hospitals located throughout 
three major counties in the state, Wayne, Oakland, and Macomb. According to the 2008 
state census (www.Michigan.gov), Wayne County has a population of 1,949,929 adults 
and represents 19.49% of the population of the state. Oakland County has a population of 
1,202,174 adults and represents 12.02% of the state population. Macomb County has a 
population of 830,663 adult individuals representing 8.3% of the population. The total 
population in the counties where the health care system is the dominant healthcare 
provider is 3,982,766 or 39.81% of the total state population. The U.S. Census Bureau’s 
2008 estimate for the state of Michigan population is 10,003,422 residents. Among these 
residents 50.8% were female, 81.2% were European American, 14.2% were African 
American, 2.4% were Asian American, and 4.1% were Hispanic American. The 
electronic medical records for this study were drawn from this tri-county population. 
A purposive stratified sampling scheme was chosen to select cases of the 
comorbid pairs for the study. As described by Trochim (2006), the purposive sampling 
approach involves accessing a particular subset of individuals through the rejection of 
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individuals who do not fit a particular profile. In the present study, the selection criterion 
of comorbidity of at least one of the psychiatric diagnoses plus at least one of the 
identified medical diagnoses was used. Trochim stated the stratified schema references 
the fact that before the sampling is done, the participants are divided into stratums or 
categories according to characteristics of importance to the research. An example of a 
stratum in the present study was the category of psychiatric disorders. From those records 
with psychiatric disorders, a further selection was made to identify those records that also 
had at least one of the identified medical diseases. The cases were selected from each of 
the stratums. Trochim wrote the stratified sampling method is as good or better than 
random sampling. 
To accomplish the case selection, the electronic medical records manager at the 
healthcare facility identified all clinical cases meeting the inclusion criterion of having at 
least one of the psychiatric diagnoses plus at least one of the medical disease diagnoses 
by using the DSM-IV psychiatric codes and f the ICD-9 medical codes. The list of 
medical record numbers (MRN) for all of the identified cases were emailed to the 
researcher to a secured computer at the health care facility. The medical record numbers 
were used to access the cases within the secured system website that housed the records. 
Statistical Power and Sample Size 
In discussing statistical power, Burkholder (2010) emphasized the importance of 
the alpha level and effect size in the calculation of the sample size needed for a study. 
Burkholder presented a number of approaches that could be used to calculate the sample 
size. In order to estimate the sample size the statistical power, alpha level, and effect size 
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must be determined. The conventionally accepted statistical power of .80 and alpha level 
of .05 suggested by Burkholder (2010) was used for this study. Determining the effect 
size requires statistical computation. The first method presented by Burkholder was 
Cohen’s d which requires a calculation of averages and use of a standard deviation value 
in the computational formula. Because the current study is categorical, and therefore non-
parametric, Cohen’s d could not be used. 
Hsieh, Bloch, and Larsen (1998) wrote that determining sample size in logistic 
regression generally involves a complicated formula because of the non-linearity of this 
statistical test. Whittemore (1981) proposed a formula based upon the Wald’s test to 
address this problem. Multinomial logistic regression provides for the prediction of a 
discrete outcome, such as group membership, from a set of variables (Demidenko, 2008). 
The Wald’s test yields the odds ratio for the success or failure of that membership with 
the projection of how many exposures will need to occur to make the determination or 
prediction. With a re-interpretation of the term ‘exposures,’ Whittemore (1981) applied 
the formula of the Wald’s test to determine sample size in epidemiological studies. 
Hsieh (1989) simplified and extended the formula presented by Whittemore for 
the purpose of a more general use (Hsieh et al., 1998). To this end, Hsieh (1989) 
constructed a sample size table for multinomial logistic regression. In this table, the event 
proportion is equated to the number of independent variables in a study and the odds ratio 
is equated to the statistical power which is the odds or probability of rejecting the null 
hypothesis when it is false given the number of dependent variables. The intercept of the 
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number of independent variables in a study and the statistical power (odds ratio) for the 
study reveals the sample size required. 
The present study used table II of the Sample Size Tables for logistic Regression 
developed by Hsieh. Given the present study has an alpha of .05 for a two-tailed test with 
P = 0 - 04 (four psychiatric diagnoses as independent variables) and odds ratio of 0 – 6 
(five medical diseases as the dependent variables), and .80 statistical power, 632 medical 
records were required to obtain an adequate sample size. 
In a review of sample size tables and statistical programs to determine sample size 
for logistic regression, Demidenko (2008) reports tables based on the Wald’s test provide 
a good estimate of sample size but adjustments may be necessary given the nature of the 
study. To ensure adequate sample size with sufficient statistical power for this study, and 
adjusting for possible cases that could not be used because of missing data, an adjustment 
was made by the researcher to increase the minimum cases required to 800 cases for the 
study. 
Data Analysis 
Data Collection Procedure 
The first step in the data collection procedure was to identify the appropriate 
DSM-IV codes for the psychiatric disorders and the ICD-9 codes for the medical diseases 
included in the study. Using these codes, the Participant Data Search Sheet (see 
Appendix A) was constructed. This Participant Data Search Sheet was given to the 
medical record staff designated by the IRB of the healthcare system who conducted a 
data based search of the electronic medical record system for the cases meeting the 
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inclusion criteria of the study. The medical record number (MRN) of each identified 
record was forwarded to the secured office computer of the researcher. The researcher 
used the MRN to access the individual records in the medical records system. The 
researcher accessed the demographics section and the documents section of the medical 
record to obtain the clinical data needed for the study. The documents included the New 
Patient Psychiatric Consultation and Evaluation, Patient History and Physical 
Examination, Intake Assessment and Evaluation. The Data Collection Sheet was used to 
record the clinical data that was coded using a pre-established data coding system (see 
Appendix B). The cases were numerically listed on the data collection sheet for later 
identification. The MRN was temporarily used for tracking purposes during data 
collection and analysis. The data collection process was a pencil and paper recording of 
coded data. The coded clinical and demographic data were entered onto the SPSS data 
file created on the home office computer of the researcher. The office computer of the 
researcher at the healthcare facility did not have SPSS software. The SPSS data file used 
by the researcher only contained encrypted data codes. The statistical analysis was 
completed using SPSS. 
Hypotheses and Analysis  
Research Question 1 
Question 1. For individuals with a comorbid psychiatric disorder and medical 
disease diagnoses, what is the association between the first type of psychiatric diagnosis 
and the first medical diagnosis? 
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Null hypothesis 1. For individuals with comorbid psychiatric disorder and 
medical disease diagnoses, there is no statistically significant association between the 
first type of psychiatric diagnosis and the first medical diagnosis. 
Alternate hypothesis 1. For individuals with comorbid psychiatric and medical 
diagnoses, there is a statistically significant association between the first type of 
psychiatric diagnosis and the first type of medical diagnosis. 
The chi-square test for independence was the statistical analysis used to test the 
null hypothesis for the first research question. This statistic is used to identify the 
likelihood of a particular outcome occurring by chance by comparing observed 
frequencies of the variable compared to expected frequencies for the variable (Gravetter 
& Wallnau, 2007). This statistical procedure was appropriate for testing the null 
hypothesis because the researcher was interested in knowing if the presence of a given 
psychiatric disorder was related to the presence of a specific medical disease. 
Research Question 2 
Question 2. Among individuals with comorbid psychiatric and medical disease 
diagnoses, to what degree does the presence of a psychiatric disorder and the 
demographic variables (gender, race, family psychiatric history, family medical history, 
and chemical dependence history) significantly predict the presence of the medical 
disorders atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and 
type II diabetes in the comorbid pairs? 
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Null hypothesis 2. The psychiatric disorders (generalized anxiety disorder, 
posttraumatic stress disorder, major depression recurrent, and dysthymic disorder) and 
the demographic variables (gender, race, family psychiatric history, family medical 
history, and chemical dependence history) are not statistically significant predictors of the 
presence of medical disorders. 
Alternate hypothesis 2. The psychiatric disorders (generalized anxiety disorder, 
posttraumatic stress disorder, major depression recurrent, and dysthymic disorder) and 
demographic variables (gender, race, family psychiatric history, family medical history, 
and chemical dependence history) are statistically significant predictors of the medical 
disorders atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and 
type II diabetes. 
Multinomial logistic regression was used to test the null hypothesis for the second 
research question. This statistical procedure predicts the probability of an individual 
being grouped into one category of a variable compared to being grouped in another 
(Mertler & Vannatta, 2005). In this study the basis of comparison was the likelihood that 
a person would be diagnosed in one category of the dependent variable, medical disorder, 
compared to another category; therefore multinomial regression was the appropriate 
statistical procedure for testing the null hypothesis. Logistic regression also offers the 
following advantages: the assumptions of linearity, normality and homogeneity of 
variance are not assumed; negative values are not produced; and logistic regression can 
consider and analyze all types of dependent and predictor variables (Mertler & Vannatta, 
2005). 
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Research Question 3 
Question 3: To what degree does the presence of a psychiatric disorder as the 
first diagnosis and the diagnosed psychiatric disorder predict the medical disorders for the 
comorbid pairs included in the study? 
Null hypothesis 3: The presence of a psychiatric disorder as the first diagnosis 
and the diagnosed psychiatric disorder are not statistically significant predictors of the 
medical disorders for the comorbid pairs included in this study. 
Alternate hypothesis 3: The presence of a psychiatric disorder as the first 
diagnosis and the diagnosed psychiatric disorder are statistically significant predictors of 
the medical disorders for the comorbid pairs included in the study. 
Multinomial logistic regression was the statistical procedure used to test the full 
model of psychiatric disorders being related to the presence of the immune based 
inflammatory diseases in this study. This was the appropriate statistic to use because this 
statistic can analyze categorical predictor variables (Peng, Lee, & Ingersoll, 2002). In 
interpreting the results in logistic regression the analysis included information on the 
overall evaluation of the logistic model, the Wald statistic for the individual predictors, 
and an assessment of the predictor probabilities (Peng et al., 2002). 
Participant/Record Confidentiality 
The medical records that were accessed were contained in a secured system of the 
healthcare network. A preset coding system (see Appendix B) was established so that 
information from the medical records could be entered on a data collection sheet using 
only the codes. No identifiable patient information was extracted from the secured 
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system. This procedure satisfied the Protected Healthcare Information (PHI) concern. 
Regarding the concern of patient consent, the Health and Human Services Policy for the 
Protection of Human Research Subjects states: 
Research involving the collection or study of existing data, documents, records, 
pathological specimens, or diagnostic specimens, if these sources are publically 
available or if the information is recorded by the investigator in such a manner 
that the subjects cannot be identified, directly or through identifiers linked to the 
subject… there is an exemption from having to obtain a consent from the patients. 
(Health and Human Services Policy for the Protection of Human Research 
Subjects, section 46.117 [4]) 
 The APA ethical standard 8.05 part (b) also states there is an exemption from the 
requirement of obtaining informed consent in the case of archival research. Approval by 
the Institutional Review Board (IRB) of Walden University and the Institutional Review 
Board of the healthcare system was not exempted. Approval to conduct the research was 
obtained from Walden University (IRB # 09-13-10-0358167) and Henry Ford Health 
System (IRB #6403).  
Maintaining confidentiality of the patients’ Protected Healthcare Information 
(PHI) is of paramount importance. The cases were viewed in the secured system of 
record system. The data from the cases were de-identified by use of a pre-established 
coding system. Only the codes were transferred to a separate data collection sheet for the 
use for entering the data and conducting the statistical analysis using SPSS programs. No 
identifiable patient information left the secured system of the hospital. 
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The Institutional Review Board of Walden University has published a document 
called The IRB Guide to Archival Research (Electronically retrieved from Walden 
University Research Center, December 23, 2009). The guide articulates the role of the 
university to protect all who have made a significant contribution to the creation of the 
records. It also serves to protect individuals who may potentially be impacted by the 
results of the research. The major sections of the archival research IRB application are: 
Project Information, General Description of the Proposed Research, Community 
Research Stakeholders and Partners, Potential Risks and Benefits, Potential Conflicts of 
Interest, Final Checklist and Electronic Signatures, and Data Confidentiality. The Walden 
University IRB does not require information regarding Data Collection Tools, 
Description of Research Participants, or Informed Consent for archival studies. 
Summary 
This chapter discussed the proposed research design, the criterion to be used for 
sample selection and sampling method proposed. This chapter also discussed the 
materials needed for the study and the statistical methods that were used to analyze the 
data. This chapter concluded with for the procedures used for protecting 
participant/medical record confidentiality as well as compliance with Walden 
University’s Institutional Review Board and the Institutional Review Board of the 
healthcare system. 
Chapter 4 will present the data, data analysis, and interpretation of the results of 
the data analyses. The chapter will discuss the hypotheses testing procedures and include 
descriptive tables as helpful for the discussion.  Chapter 5 will provide an overview of 
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why the study was conducted, review the research questions, and present a summary of 
the findings of the analysis. Chapter 5 will conclude with a presentation of the 
implications for social change and recommendations for action as a result of the findings 
of the study. 
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Chapter 4: Results 
Introduction 
This study investigated the degree to which four psychiatric disorders predict the 
presence of five medical diseases. The predictor variables in the study were psychiatric 
disorders, demographic variables, and biological factors. The specific psychiatric 
disorders investigated included generalized anxiety disorder, posttraumatic stress 
disorder, major depression recurrent, and dysthymic disorder. The demographic variables 
were age, race, and gender. The biological factors included in the study were family 
history of the psychiatric disorders, family history of the medical disorders, and 
individual history of chemical dependence. The medical, immune-based inflammatory 
diseases served as the dependent variables. The medical diseases investigated in the study 
were atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and type 
II diabetes. 
This chapter provides a description and summary of the data collected in the 
study. The research method consisted of a parallel archival design (Trochim, 2006). Data 
were collected from electronic medical records of a large healthcare system. A purposive 
stratified sampling schema was used to select the cases. A two-tailed alpha level of .05 
and statistical power of .80 was accepted as the criteria for judging the significance of the 
statistical analyses performed for this study. The Sample Size for Logistic Regression 
Table published by Hsieh, Bloch, and Larsen (1998) was used to determine the minimum 
sample size needed to meet the criteria for statistical power for the study. The table uses 
the number of predictors and the number of exposures or occurrences of an event to 
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calculate the minimum number of participants or cases needed to achieve a desired level 
of statistical power. Given the four psychiatric disorders as the predictor variables, the 
five medical diseases as the possible events, with alpha set of .05 for a two-tail 
distribution and, a statistical power of .80, a review of the table revealed that 632 cases 
would be needed for the study. Because this study involved the use of secondary data, the 
researcher decided to increase the sample size to a minimum of 800 medical records. The 
minimum number of cases was increased to accommodate the possibility of attrition of 
records that could not be used because of missing data. 
A secondary data analysis was employed to analyze the data that were collected. 
Three statistical analyses were performed on the data. A descriptive cross tabulation was 
used to summarize the demographic characteristics of the sampled cases. A chi-square 
test of independence was used to test the null hypothesis for the first research question. A 
multinomial logistic regression was used to test the null hypotheses for the second and 
third research question. Results of the Wald’s test, the Nagelkerke Pseudo R-square 
value, and the odds-likelihood ratio were used to judge the significance of results from 
the multinomial logistic regression. The following paragraphs present results of the 
descriptive data, research questions and relevant hypotheses, summary of the relevant 
statistical procedures, and results for each research question. 
Data Collection and Screening 
After gaining permission to collect data from Walden University’s Institutional 
Review Board and the Institutional Review Board of the health care facility, the 
researcher accessed data from the electronic databases of the health care facility. Four 
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medical documents were accessed to gather data. The documents consisted of the New 
Patient Evaluation Psychiatric Consultation, History and Physical Evaluation, New 
Patient Intake and Assessment, and Patient Demographics. As a member of the clinical 
staff, the researcher had the appropriate training and security clearance to use the 
electronic medical record system. The healthcare system agreed to permit review of the 
cases on the secured system on the condition that no personally identifying information 
would be recorded from the patient records. Therefore, no information regarding patient 
names, social security number, home address, telephone number, or other personally 
identifying information was recorded on the researcher constructed data collection sheet. 
For tracking purposes during the data collection stage, the researcher used the assigned 
medical record number (MRN) for each case. The MRN was used to track the cases 
during the data collection and analysis phases of the research. 
The first step of the data collection consisted of grouping the four psychiatric 
disorders and the five medical diseases into comorbid pairs. The pairs were formed by 
pairing the diagnostic codes from the Diagnostic and Statistical Manual of Mental 
Disorders, 4th edition (DSM-IV; APA, 2000) for the psychiatric disorders investigated in 
the study with relevant medical diagnostic codes from the International Classification of 
Diseases, 9th Revision (ICD-9) for the medical diseases in this study. The grouping of the 
disorders resulted in a total of 20 comorbid pairs. This comorbid pair grouping 
information was then used to develop the Participant Data Search Sheet (see Appendix 
A) that was used as a guide for the selection of cases. Therefore cases included in the 
study were selected by first identifying cases in which one of the four identified 
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psychiatric disorders (generalized anxiety disorder, posttraumatic stress disorder, major 
depression recurrent, or dysthymic disorder) was the first occurring psychiatric diagnosis. 
The next step was to select records from that database search which also contained cases 
which included the ICD-9 medical codes that were used for the five medical diseases 
included in this study. 
The next screening of the database identified the cases with which one of the 
medical diseases (atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, 
cancer, or type II diabetes) was also listed as the primary medical disease for those cases. 
Results from the first database search and record screening contained records which were 
comprised of comorbid pair cases with the four primary psychiatric and the five primary 
medical disease identified for each case. By convention, the health care system considers 
the first diagnosis listed in a case to be the primary diagnosis. 
The database search used two search parameters to select cases for the study. The 
first parameter selected cases from the one year population cycle that spanned from 
January 1, 2009 to December 31, 2009. The purpose of the first search parameter was to 
capture the most current health status information in the medical records. The second 
search parameter screened for patients with birthdates which occurred before January 1, 
1990. Following the groundwork established by previous researchers (Baumeister et al., 
2005; Boscarino, 1997; Wells et al., 1991), this study restricted the selection of records to 
adult cases where the patient was 21 years of age or older. The purpose for restricting the 
records to those who were 21 years old or older was to avoid potential confounding of the 
data related to shifting between pediatric psychiatry assessments and adult psychiatry 
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assessments (Gregory, 2007). There are also distinct developmental and psychosocial 
differences between the two age categories (Santrock, 2007). The result from the first 
database search screened 8,133 medical records with the primary psychiatric diagnoses 
specified in the study. Among those records, the occurrences for 17 comorbid pairs were 
found. Appendix C provides a descriptive summary of the findings from the first database 
search. The first database search only yielded 480 cases that met the inclusion criterion. 
The researcher specified 800 medical records would be needed to achieve adequate 
statistical power for this study. Consequently an additional search was made of the 
database. 
The second database search was conducted by expanding the population cycle to 
include cases from January 1, 2005 to September 30, 2010. The year 2005 was selected 
because it was the time in which the behavioral services division of the healthcare facility 
began to use the electronic medical record system. The second search produced over 
40,000 potential cases. After applying the inclusion criteria for the records, the number of 
potential cases was reduced to 2,914 cases or approximately 14% of the originally 
identified cases. In an initial screening of the records selected from the database, the 
researcher noted that many of the cases had more than one medical diagnosis listed 
(multiple pairs), which resulted in an inflated count for the number of cases found. A 
correction was made by selecting only the first occurring medical diagnosis for each case. 
Once the psychiatric and medical disorders were determined, each case was then assigned 
to one of the comorbid pairs. 
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The fourth step in the data collection process was to access the actual electronic 
medical records in the secured system using the MRN for each of the selected cases to 
gain access to the record. The purpose of this step was to obtain the biological and 
demographic information. Shortly after the start of the review of the medical records for 
the demographic data it became obvious there were redundancies in the data entries. 
Some of the cases appeared to have more than one psychiatric disorder listed as the first 
diagnosis. 
The researcher concluded that as patients continued seeking treatment at the 
facility, sometimes changes would occur in their primary psychiatric diagnosis resulting 
in more than one diagnosis of a psychiatric disorder. By expanding the database search to 
five years in the second search, the computer generated more than one case placement for 
some patients. The researcher halted the data collection from the chart reviews to locate 
and eliminate the redundant records by using the method described in the next paragraph. 
To locate and eliminate multiple placements of cases, the MRNs were copied on 
to a blank sheet. Using the Sort & Filter function of the spreadsheet software, all of the 
MRNs were listed in numerical order. This listing caused all duplicate record numbers to 
cluster. Next, the researcher used the Microsoft select & find function to locate all of the 
duplicate MRN’s. The researcher used the procedure of selecting the first occurring 
diagnosis and removing the redundant cases from the data collection sheets. This process 
also allowed the researcher to confirm that all of the cases were listed in the correct 
comorbid pair category. 
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After deleting the redundant cases from the data file, the final case count was 
1,209. This number represented approximately 3% of the original 40,000 cases generated 
from the five year span specified in the second database search. The number further 
showed that of the 1,209 cases of the occurring comorbid pairs, 66.7% of the cases listed 
a psychiatric diagnoses as the first diagnosis of the comorbid pair. 
Table 1 presents a summary of the demographic information of the cases included 
in the study. The table shows the frequency count of the number of cases with a first 
diagnosis of psychiatric disorder, the specified psychiatric disorder, and the medical 
disorders. Results showed almost 67% of the cases had a psychiatric disorder as the first 
disorder in the record. Dysthymic disorder, which was present in 37.5% of the records, 
was the most frequently occurring psychiatric disorder. Type II diabetes, which was 
present in 64.9% of the records was the most frequently occurring medical disorder. 
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Table 1 
Summary descriptive statistics of whether the first diagnosis was a psychiatric diagnosis, 
type of psychiatric diagnoses and type of medical diagnoses 
 
Variable Frequency Percent Valid Percent 
Cumulative 
Percent 
First diagnosis psychiatric 
yes 807 66.7 66.7 66.7 
no 402 33.3 33.3 100.0 
Total 1209 100.0 100.0  
psychiatric diagnosis 
generalized anxiety disorder 
266 22.0 22.0 22.0 
posttraumatic stress disorder 
63 5.2 5.2 27.2 
major depression recurrent 
427 35.3 35.3 62.5 
dysthymic disorder 453 37.5 37.5 100.0 
Total 1209 100.0 100.0  
medical diagnosis 
atherosclerosis 173 14.3 14.3 14.3 
cardiovascular heart disease 
19 1.6 1.6 15.9 
rheumatoid arthritis 136 11.2 11.2 27.1 
cancer 96 7.9 7.9 35.1 
type II diabetes 785 64.9 64.9 100.0 
Total 1209 100.0 100.0  
Note. The highest percent values are in boldface. 
 
Demographic Characteristics 
The case medical records were accessed from the Behavioral Services Division of 
a single healthcare entity comprised of a system of hospitals and outpatient clinics 
located in the state of Michigan. The healthcare system services a population area that 
has almost four million residents. The population served by the facility represents 40% of 
the residents in the state. Table 2 presents the acronyms that will be used to identify the 
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psychiatric and medical disorders. This table can be used to aid in interpreting the data 
presented in table 3 and throughout the chapter. 
Table 2 
List of Acronyms Used to Identify the Psychiatric and Medical Disorders 
Acronym Disorder/Disease 
GAD Generalized Anxiety Disorder 
PTSD Posttraumatic Stress Disorder 
MDD Major depression Recurrent 
DD Dysthymic disorders 
Athero Atherosclerosis 
CVD Cardiovascular heart disease 
RA Rheumatoid arthritis 
CA Cancer 
DM Type II diabetes 
 
The sample for this study consisted of 1,209 cases. Table 3 presents a summary of 
the demographic information for the cases. The table was constructed from the results 
generated from the SPSS descriptive cross tabulation procedure. The results reveal that 
the sample contained 391 males (36%) and 689 females (64%). 
Table 3 also reveals that the rates of occurrence for the specific comorbid pairings 
varied within the specific demographic categories. For instance, females had the highest 
occurrence among all of the comorbid categories for which the psychiatric disorder was 
the first diagnosis to occur. Females had the highest rates of occurrence for four out of 
five comorbid pairings related to generalized anxiety disorder; four out of five categories 
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for pairings related to major depression recurrent; three out of five categories of 
comorbid pairings related to posttraumatic stress disorder; and three out five comorbid 
pairings related to dysthymic disorder. Males had the highest rates of occurrence for all 
of the comorbid pairings related to the medical diagnosis of atherosclerosis. Males also 
had the highest rates of occurrence with pairings for dysthymic disorder and 
cardiovascular heart disease. 
Table 3 provides a summary of the data regarding the race or ethnicity for the 
records included in the study. The table shows that among the 1,209 cases reviewed, 680 
were European Americans (63%), 351 were African Americans (32%), 11 were Asian 
Americans, and 8 were Hispanic Americans. Cumulatively, the Asian American and 
Hispanic American comprised less than 5% of the cases reviewed. There were thirty 
cases in the ‘other’ racial category. In determining whether or not the sample obtained for 
this study was representative of the demographic mix in the State of Michigan, the report 
by the 2008 census was used for comparison. The comparison revealed the European 
Americans were underrepresented in this sample. African Americans were 
overrepresented in the sample. Asian Americans and Hispanic Americans were 
underrepresented in the sample. The representativeness of the sample obtained has 
important implications for interpreting the findings, for generalizing conclusions, and for 
suggesting future research. 
The data revealed that African Americans had the highest rates of occurrence for 
three of the five comorbid pairings for PTSD. European Americans had the highest rates 
of occurrence for all of the other comorbid pairs in the study. In considering family 
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history and lifestyle, Table 3 reveals there was no family history of psychiatric disorder 
in 80% of the cases. There was no family history of the immune based inflammatory 
diseases central to this study in 75% of the cases. In 87% of the cases there was no 
history of chemical dependence. The one comorbid pair exception whereby family 
history had a high rate of occurrence was dysthymic disorder and rheumatoid arthritis. 
Table 3 
 
Descriptive Summary of Cases of Comorbidity Pairs and Demographic Variables 
 
Co- 
morbid 
Pair 
 
n 
Gender  Race/Ethnicity   Family  
Psy. 
Historya  
Family 
Medical 
Historya 
 
 
Chem 
Depend.
Historya 
 
Male 
 
Female 
Asian 
Amer. 
African  
Amer. 
European 
Amer. 
Hispanic 
Amer. Other 
GAD/ 
Athero 
20  55% 45% 
  
25%  70% 
  5.0% 
 35%  25% 20% 
GAD/ 
CVD 
5  20%   80% 
  
 20%  80% 
    
 0%  20%  0% 
GAD/ 
RA 
29  10%   90% 
  
 28%  72% 
    
 31%  17%   17% 
GAD/ 
CA 
 22  27%  73%  
  
 18%  82% 
    
 14%  41%  23% 
GAD/ 
DM 
 190  40%  60% 
2.1% 
 32%  61% 
1.1% 4.2% 
 23%   23%  15%  
PTSD/ 
Athero 
7   71%  29% 
  
 57%   43%  
    
 0%  43%  14% 
PTSD/ 
CVD 
0  0%   0% 
  
 0%  0%  
    
 0%  0%  0% 
PTSD/ 
RA 
10  40%  60% 
  
 70%  30% 
    
 10%  0%  20% 
PTSD/ 
CA 
3   33%   67% 
  
 33%   67% 
   
 0%  33%  0% 
PTSD/ 
DM 
43  46%  54% 
 
 61%  37% 2.3%   9%  28%  7%  
MDD/ 
Athero 
 107  55%  45% 
.9%  20%  77% .9%  1.9%   16%  23%  16% 
MDD/ 
CVD 
10  40%   60% 
  
 50%  50%    0%  40%   10% 
MDD/ 
RA 
39  13%   87% 
  
 23%  72%  2.6% 2.6%  15%  3%  10% 
MDD/ 
CA 
 52  29%  71% 
  
 33%  64% 1.9% 1.9%  19%  21%  25% 
MDD/ 
DM  
219  28%  72% 
.9%  33%  65%  .9%  16%  23%  11% 
DD/ 
Athero 
39  59%  41% 2.6%  8%  87%  2.6%  10%  26%  10% 
DD/ 
CVD  
 
4  75%  25% 
  
 0%  100%    0%  0%  0% 
DD/RA 
 
58  19%  81% 1.7%  31%  64%   3.4%  21%  2%  14% 
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DD/CA 
 
19  16%   84% 
 
 5%  95%    11%   58%  5% 
DD/DM 
 
333   36%   64% 
.6%  37%   58%  .6% 3.9%  17%  26%   11% 
Note. N = 1,209 for the total sample. The percentages are of cases for which the answer 
was ‘yes’. 
 
One of the criteria of the study was that all individuals with cases reviewed in this 
study would currently be 21 years of age or older. The purpose of the age restriction to 
adult cases was to control for possible confounding data from pediatric psychiatric 
evaluations verses data obtained from adult psychiatric evaluations (Gregory, 2007). The 
psychosocial and developmental differences between adults and children were also a 
factor in selecting only one age population (Santrock, 2007). As presented in Table 4, the 
greatest concentration across all of the age categories in the comorbid pairs were cases of 
individuals who were 50 years of age and older. Table 4 also reveals high mortality rates 
in the comorbid pairs related to generalized anxiety disorder and cancer (50%), 
posttraumatic stress disorder and cancer (33.3%), major depression recurrent and 
atherosclerosis (30%), major depression recurrent and cancer (48.1%), and dysthymic 
disorder and cancer (73.7%). Although the mortality rate reflects a pattern among the 
comorbid pairs with European American females in the demographic data collected for 
this study; causation cannot be inferred. 
Table 4 
Frequency summary from the descriptive cross tabulation for current age in years with 
the comorbid pairs included in the study. 
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Note. See Table 2 for acronym references 
Comorbid 
Age/ Frequency current age in years Total 
  Pairs 21 to 35  36 to 49  50 above Deceased  
GAD/Athero  
n 
0 1 16 3 20 
 Expected n .5 2.6 15.3 1.6 20.0 
 % of pairs .0% 5.0% 80.0% 15.0% 100.0% 
 n 0 0 5 0 5 
GAD/CVD Expected n .1 .6 3.8 .4 5.0 
  % of pairs .0% .0% 100.0% .0%. 100.0% 
 n 1 5 22 1 29 
GAD/RA Expected n .8 3.7 22.2  2.3 
 
29.0 
  % of pairs 3.4% 17.2% 75.9% 3.4% 100.0% 
 n 0 1 10 11 22 
GAD/CA Expected n .6 2.8 16.8 1.7 22.0 
  % of pairs .0% 4.5% 45.5% 50.0%. 100.0% 
 n 11 23 151 5 190 
GAD/DM Expected n 5.0 24.4 145.4 15.1 190.0 
  % of pairs 5.8% 12.1% 79.5% 2.6% 100.0% 
 n 0 0 6 1 7 
PTSD/Athero Expected n .2 .9 5.4 .6 7.0 
 % of pairs .0% .0% 85.7% 14.3% 100.0% 
 n 0 2 8 0 10 
PTSD/RA Expected n .3 1.3 7.7 .8 10.0 
  % of pairs .0% 20.0% 80.0% .0% 100.0% 
 n 1 0 1 1 3 
PTSDCA Expected n .1 .4 2.3 .2 3.0 
  % of pairs 33.3% .0% 33.3% 33.3% 100.0% 
 n 0 12 30 1 43 
PTSD/DM Expected n 1.1 5.5 32.9 3.4 43.0 
  % of pairs .0% 27.9% 69.8% 2.3% 100.0% 
 n 0 6 95 6 107 
MDD/Athero Expected n 2.8 13.7 81.9 8.5 107.0 
  % of pairs .0% 5.6% 88.8% 5.6% 100.0% 
 n 0 0 7 3 10 
MDD/CVD Expected n .3 1.3 7.7 .8 10.0 
  % of pairs .0% .0% 70.0% 30.0% 100.0% 
MDD/RA n 1 7 31 0 39 
 Expected n 1.0 5.0 29.8 3.1 39.0 
  % of pairs 2.6% 17.9% 79.5% .0% 100.0% 
 n 1 3 23 25 52 
MDD/CA Expected n 1.4 6.7 39.8 4.1 52.0 
  % of pairs 1.9% 5.8% 44.2% 48.1% 100.0% 
 n 1 24 186 8 219 
MDD/DM Expected n 5.8 28.1 167.6 17.4 219.0 
  % of pairs .5% 11.0% 84.9% 3.7% 100.0% 
 n 0 1 37 1 39 
DD/Athero Expected n 1.0 5.0 29.8  3.1 
 
39.0 
  % of pairs .0% 2.6% 94.9% 2.6% 100.0% 
 n 0 0 4 0 4 
DD/CVD Expected n .1 .5 3.1 .3 4.0 
  % of pairs .0% .0% 100.0% .0% 100.0% 
 n 3 10 43 2 58 
DD/RA Expected n 1.5 7.4 44.4 4.6 58.0 
  % of pairs 5.2% 17.2% 74.1% 3.4% 100.0% 
 n 0 1 4 14 19 
DD/CA Expected n .5 2.4 14.5 1.5 19.0 
 % of pairs .0% 5.3% 21.1% 73.7% 100.0% 
 n 13 59 246 14 333 
DD/DM Expected n 8.8 42.7 254.8 26.4 333.0 
  % of pairs 3.9% 17.7% 73.9% 4.2% 100.0% 
 Total n 32 155 925 96 
 
1209 
 
Expected n 32.0 155.0 925.0 96.0 1209.0 
 
% pairings 2.6% 12.8% 76.5% 7.9% 100.0% 
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The data also revealed that in 75% of the individuals were 50 years of age or older 
at the time of their first psychiatric diagnosis. The data also showed that 78% of the cases 
were of individuals who were 50 years old or older at the time of their first medical 
diagnosis. Fifty percent of the cases revealed the diagnosis of the comorbid condition 
within one year of the first diagnosis, either psychiatric or medical. 
Research Questions and Data Analysis 
The purpose of this study was to determine if the diagnosis of certain psychiatric 
disorders was related to the subsequent onset of certain medical diseases. Three research 
questions were posed for this study. The results from the data analysis related to testing 
the null hypotheses for each question is presented below. 
Research Question 1 
Question 1: For individuals with comorbid psychiatric disorder and medical disease 
diagnoses, what is the association between the first type of psychiatric diagnosis and the 
first medical diagnosis? 
Null hypothesis 1: For individuals with comorbid psychiatric disorder and medical 
disease diagnoses, there is no statistically significant association between the first type of 
psychiatric diagnosis and the first medical diagnosis. 
Alternate hypothesis 1: For individuals with comorbid psychiatric and medical 
diagnoses, there is a statistically significant association between the first type of 
psychiatric diagnosis and the first type of medical diagnosis. 
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The chi-square test for independence was the statistical analysis used to test the 
null hypothesis for the first research question. This statistic is used to identify the 
likelihood of a particular outcome occurring by chance by comparing observed 
frequencies of the variable compared to expected frequencies for the variable (Gravetter 
& Wallnau, 2007). This statistical procedure was appropriate for testing the null 
hypothesis because the researcher was interested in knowing if the presence of a given 
psychiatric disorder was related to the subsequent development of medical diseases. As 
presented in Table 5, results of the chi-square analysis revealed that there was a 
statistically significant relationship between the rate of occurrence of the psychiatric 
condition first, and the subsequent diagnosis of the comorbid condition. The observed 
Pearson chi-square was X2 (12, N = 1,209) = 99.528, p = .000. The null hypothesis was 
rejected because the obtained p value was less than .05. A review of the data in Table 5 
revealed the rate of occurrence of cases with atherosclerosis and type II diabetes occurred 
at a greater rate than expected. The rates of occurrence of cases with major depression 
with type II diabetes also occurred at a greater rate than expected. In addition, the rates of 
occurrence of cases with dysthymic disorder and type II diabetes occurred at a greater 
rate than expected. Data from Table 5 further revealed that the greatest rate of comorbid 
pairing of psychiatric disorders was related to the medical diagnosis of type II diabetes. 
The next research question addressed the degree to which the first psychiatric diagnosis 
and certain demographic variables predicted the occurrence of the specified medical 
disorders. 
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Table 5 
Chi-square Test of Independence for Association between the Psychiatric Diagnosis and 
Medical Diagnosis 
 
   medical diagnosis  
           
Psychiatric   
Diagnosis  Count 
Athero-
sclerosis 
Cardio-
vascular heart 
disease 
rheumatoid 
arthritis cancer 
type II 
diabetes Total 
generalized   
anxiety   
disorder 
    
Count 20 5 29 22 190 266 
Expected 
Count 38.1 4.2 29.9 21.1 172.7 266.0 
% within 
psychiatric 
diagnosis 7.5% 1.9% 10.9% 8.3% 71.4% 100.0% 
  
Post-
traumatic  
stress  
disorder 
 
Count 7 0 10 3 43 63 
Expected 
Count 9.0 1.0 7.1 5.0 40.9 63.0 
% within 
psychiatric 
diagnosis 
11.1% .0% 15.9% 4.8% 68.3% 100.0% 
  
major  
depression   
 recurrent 
  
  
  
Count 107 10 39 52 219 427 
Expected 
Count 61.1 6.7 48.0 33.9 277.2 427.0 
% within 
psychiatric 
diagnosis 25.1% 2.3% 9.1% 12.2% 51.3% 100.0% 
dysthymic   
disorder  
  
  
  
Count 39 4 58 19 333 453 
Expected 
Count 64.8 7.1 51.0 36.0 294.1 453.0 
% within 
psychiatric 
diagnosis 
8.6% .9% 12.8% 4.2% 73.5% 100.0% 
    Total Count 173 19 136 96 785 1209 
  
Expected 
Count 173.0 19.0 136.0 96.0 785.0 1209.0 
  
% within 
psychiatric 
diagnosis 
14.3% 1.6% 11.2% 7.9% 64.9% 100.0% 
Note. Psychiatric and medical pairs exceeding the expected count are boldfaced. 
 
Research Question 2 
Question 2: Among individuals with comorbid psychiatric and medical disease 
diagnoses, to what degree does the presence of a psychiatric disorder and the 
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demographic variables (gender, race, family psychiatric history, family medical history, 
and chemical dependence history) significantly influence the presence of the medical 
disorders atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and 
type II diabetes in the comorbid pairs? 
Null hypothesis 2: The psychiatric disorders (generalized anxiety disorder, posttraumatic 
stress disorder, major depression recurrent, and dysthymic disorder) and the demographic 
variables (gender, race, family psychiatric history, family medical history, and chemical 
dependence history) are not statistically significant predictors of the medical disorders. 
Alternate hypothesis 2: The psychiatric disorders (generalized anxiety disorder, 
posttraumatic stress disorder, major depression recurrent, and dysthymic disorder) and 
demographic variables (gender, race, family psychiatric history, family medical history, 
and chemical dependence history) are statistically significant predictors of the medical 
disorders atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and 
type II diabetes. 
Multinomial logistic regression was used to test the null hypothesis for the second 
research question. This statistical procedure predicts the probability of an individual 
being grouped into one category of a variable compared to being grouped in another 
(Mertler & Vannatta, 2005). In this study the basis of comparison was the likelihood that 
a person would be diagnosed in one category of the dependent variable, medical disorder, 
compared to another category; therefore multinomial regression was the appropriate 
statistical procedure for testing the null hypothesis. Logistic regression also offers the 
following advantages: the assumptions of linearity, normality and homogeneity of 
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variance are not assumed; negative values are not produced; and logistic regression can 
consider and analyze all types of dependent and predictor variables (Mertler & Vannatta, 
2005). 
The dependent variable in the equation was the medical disorder (atherosclerosis, 
cardiovascular heart disease, rheumatoid arthritis, cancer, and type II diabetes). The 
independent/predictor variables in the equation were the presence of one of the 
psychiatric disorders, age, gender, race/ethnicity, family history of a similar psychiatric 
and/or medical disease diagnosis, and history of chemical dependence. 
The default option in SPSS is to either use the first group or the last group of the 
dependent variable as the reference or comparison group (SPSS, version 15). In this study 
SPSS used the last variable, which was type II diabetes, as the reference group for the 
group comparisons. The parameter estimates for the model shows the results for each 
variable included in the model. Results revealed that the model had the greatest 
classification accuracy of 96.4% for predicting type II diabetes from the independent 
variables. The overall classification accuracy for this model was 65%. 
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Table 6 
Multinomial logistic regression classification table for the medical diagnoses 
 
 Observed 
   Predicted Frequencies      Total 
   Frequencies 
Athero-
sclerosis cancer 
type II 
diabetes 
Percent 
Correct 
atherosclerosis 18 1 154 10.4% 
cardiovascular heart 
disease 2 0 17 .0% 
rheumatoid arthritis 2 0 134 .0% 
cancer 4 0 92 .0% 
type II diabetes 16 1 768 97.8% 
Overall Percentage 3.5% .2% 96.4% 65.0% 
N = 1,209. Table is adapted from the SPSS output. 
 
Results from the omnibus table of the multinomial logistic regression revealed 
that the variables psychiatric diagnosis, first diagnosis psychiatric, gender, and family 
history of the medical diagnosis were statistically significant predictors of the type of 
comorbid medical diagnosis. Based upon the findings of these analyses, the null 
hypothesis was rejected. The chi-square results from the omnibus tests of the model 
coefficients revealed X2(52, 1,209) = 266.587, p = .000, which was statistically 
significant. The Nagelkerke Pseudo R-Square provided a measure of how well the 
independent variables in the equation predicted the dependent variable (Gravetter & 
Wallnau, 2007). The Nagelkerke pseudo R-square of .224 in this analysis indicates that 
22.4% of the variance in the medical disease category was accounted for by the 
psychiatric disorders plus the demographic and biological factors. This variance indicates 
a large effect size (Gravetter & Wallnau, 2007). 
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The results from the likelihood ratio tests, as presented in Table 8 revealed that 
the presence of a psychiatric disorder, the type of psychiatric disorder, gender, and 
history of a family member with a related medical disorder were statistically significant 
predictors of the type of medical disorder. Table 7 presents the legend for the acronyms 
used in Table 8. 
Table 7 
Legend for the variable names used in Table 8 
psydx – psychiatric diagnosis 
firstdx – first diagnosis psychiatric 
cdhx – chemical dependence history 
gender – gender 
fammed – family history of the medical diagnosis 
fampsy – family history of the psychiatric disorder 
raceeth – race/ethnicity 
 
Table 8 
Psychiatric and demographic predictors for comorbidity 
 
Effect 
Model Fitting 
Criteria Likelihood Ratio Tests 
  
-2 Log 
Likelihood of 
Reduced 
Model Chi-Square df Sig. 
Intercept 903.385(a) .000 0 . 
psydx 1006.984 103.600 12 .000 
firstdx 923.812 20.428 4 .000 
cdhx 912.255 8.871 4 .064 
gender 964.273 60.888 4 .000 
fammed 939.002 35.617 4 .000 
fampsyc 911.748 8.364 4 .079 
raceeth 928.722 25.338 16 .064 
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a This reduced model is equivalent to the final model because omitting the effect does not 
increase the degrees of freedom. 
b. Significant results are boldfaced 
 
The Wald statistic was next used to determine the degree to which each of the 
predictor variables contributed to the regression model (Mertler & Vannatta, 2005). 
Regarding the occurrence of the medical disorder atherosclerosis, the results from the 
Wald statistics presented in Table 10 show that the type of psychiatric disorder, the 
presence of a psychiatric diagnosis as the first diagnosis for the comorbid pair, and 
gender were statistically significant predictors of atherosclerosis. The data further 
revealed that males with a first diagnosis of major depressive disorder were significantly 
more likely to have a medical diagnosis of atherosclerosis than type II diabetes. 
Regarding the occurrence of cardiovascular heart disease, the data revealed that 
only one variable in the equation was a significant predictor. Results from the Wald 
statistic reveal that individuals with a first psychiatric diagnosis of major depression 
recurrent were significantly more likely to develop cardiovascular heart disease than type 
II diabetes. However it must be noted that the omnibus Wald statistic for this variable 
was not statistically significant. Therefore the finding for this variable may be a spurious 
result. 
Regarding the occurrence of the medical disease rheumatoid arthritis, the results 
from the Wald statistics indicated that the presence of psychiatric diagnosis as the first of 
the comorbid pair, gender, and family medical history were significant predictors for the 
disease. The data further revealed that males with a psychiatric disorder, who also had a 
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family history of rheumatoid arthritis, were significantly more likely to have a medical 
diagnosis of rheumatoid arthritis than type II diabetes. 
Regarding the occurrence of the medical disease cancer, the results from the Wald 
statistics, the presence of a psychiatric disorder for the first comorbid pair, having the 
psychiatric diagnosis of major depression recurrent, history of chemical dependence, and 
male gender were significant predictors of the disease. The result specially showed that 
males with the psychiatric diagnosis of major depression who had a history of chemical 
dependence were significantly more likely to develop cancer than type II diabetes. 
Table 10 presents the results of the multinomial logistic regression analysis using 
the dependent and independent variables. Table 9 presents a legend for interpreting the 
variable names in Table 10. 
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Table 9 
Legend for interpreting variables in Table 10 
Psychiatric (psydx) 
 
Generalized Anxiety Disorder =1 
Posttraumatic Stress Disorder = 2 
Major Depression Recurrent = 3 
Dysthymic Disorder = 4 
First Diagnosis Psychiatric (firstdx) 
Yes = 1 
No = 2 
Chemical Dependence History (cdhx) 
Yes = 1 
No = 2  
Gender (gender) 
Male = 1 
Female = 2 
Race/Ethnicity (raceeth)  
Asian American = 1 
African American = 2 
European American = 3 
Hispanic American = 4 
Other = 5 
Family Medical History (fammed) 
Yes = 1 
No = 2 
Unknown/Adopted = 3 
Family Psychiatric History (fampsy) 
Yes = 1 
No = 2 
Unknown/Adopted = 3 
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Table 10 
Multinomial logistic regression analysis of the dependent and independent variables 
Study                B           Std. Error   Wald           df              Sig.      Exp(B)     95% Confidence Interval 
Variables                                                                                                                        for Exp (B) 
                                                                                                                           Lower Bound/ Upper Bound  
Atherosclerosis 
Intercept 
-15.955 .668 569.872 1 .000       
[psydx=1] 
-.181 .296 .373 1 .541 .835 .468 1.490 
[psydx=2] 
.189 .448 .177 1 .674 1.208 .502 2.908 
[psydx=3] 1.502 .212 50.289 1 .000 4.490 2.965 6.800 
[psydx=4] 0(b) . . 0 . . . . 
[firstdx=1] 
-.405 .189 4.593 1 .032 .667 .460 .966 
[firstdx=2] 0(b) . . 0 . . . . 
[cdhx=1] 
.043 .261 .027 1 .869 1.044 .626 1.742 
[cdhx=2] 0(b) . . 0 . . . . 
[gender=1] 
.994 .183 29.655 1 .000 2.702 1.890 3.865 
[raceeth=2] 13.302 .000 . 1 . 598210.048 598210.048 598210.048 
[fammed=1] 
.399 .665 .359 1 .549 1.490 .404 5.488 
[fammed=2] 
.288 .650 .197 1 .657 1.334 .373 4.773 
[fampsyc=1] 
-.017 .245 .005 1 .945 .983 .608 1.589 
Cardiovascular Heart Disease 
Intercept 
-30.156 972.761 .001 1 .975       
[psydx=1] 
.833 .682 1.491 1 .222 2.300 .604 8.753 
[psydx=2] 
-12.543 658.875 .000 1 .985 3.57E-006 .000 .(c) 
[psydx=3] 1.392 .603 5.327 1 .021 4.021 1.234 13.110 
[firstdx=1] 
-.588 .480 1.498 1 .221 .555 .217 1.424 
[cdhx=1] 
-.849 1.050 .654 1 .419 .428 .055 3.349 
[gender=1] 
.478 .482 .986 1 .321 1.613 .628 4.146 
[raceeth=2] 13.120 .000 . 1 . 498810.878 498810.878 498810.878 
[fammed=1] 13.104 972.761 .000 1 .989 490835.220 .000 .(c) 
[fammed=2] 13.055 972.761 .000 1 .989 467573.723 .000 .(c) 
[fampsyc=1] 
-13.170 354.442 .001 1 .970 1.91E-006 3.79E-308 9.593E+295 
                                                                                                                                                                                                                                      
(table continues) 
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Study                B           Std. Error   Wald           df              Sig.      Exp(B)     95% Confidence Interval 
Variables                                                                                                                          for Exp (B) 
                                                                                                                           Lower Bound/ Upper Bound  
Rheumatoid Arthritis 
Intercept 
.302 1.365 .049 1 .825       
[psydx=1] 
-.187 .254 .540 1 .462 .830 .504 1.365 
[psydx=2] 
.482 .399 1.458 1 .227 1.619 .741 3.537 
[psydx=3] 
-.015 .232 .004 1 .948 .985 .625 1.552 
[firstdx=1] 
-.721 .193 13.891 1 .000 .486 .333 .711 
[cdhx=1] 
.331 .289 1.313 1 .252 1.392 .790 2.452 
[gender=1] 
-1.013 .250 16.407 1 .000 .363 .222 .593 
[raceeth=2] 
-1.167 1.239 .887 1 .346 .311 .027 3.531 
[fammed=1] 
-1.714 .686 6.242 1 .012 .180 .047 .691 
[fammed=2] 
-.013 .576 .000 1 .982 .987 .319 3.053 
[fampsyc=1] 
-.013 .245 .003 1 .959 .987 .611 1.596 
Cancer 
Intercept 
-15.699 .814 372.285 1 .000       
[psydx=1] 
.723 .330 4.795 1 .029 2.062 1.079 3.940 
[psydx=2] 
.227 .647 .124 1 .725 1.255 .354 4.458 
[psydx=3] 1.388 .285 23.814 1 .000 4.009 2.295 7.002 
[firstdx=1] 
.272 .258 1.110 1 .292 1.312 .791 2.176 
[cdhx=1] 
.791 .299 7.014 1 .008 2.205 1.228 3.960 
[gender=1] 
-.517 .256 4.069 1 .044 .596 .361 .985 
[raceeth=2] 12.528 .000 . 1 . 275845.043 275845.043 275845.043 
[fammed=1] 
.568 .790 .517 1 .472 1.765 .375 8.308 
[fammed=2] 
.051 .778 .004 1 .948 1.052 .229 4.835 
[fampsyc=1] 
-.252 .308 .669 1 .413 .777 .424 1.422 
 
Note. Statistically significant results are in boldface.  
a. Type II diabetes was the reference/comparison category 
 
The multinomial logistic regression analysis was conducted to test null hypothesis 
2 in this study. The null hypothesis stated that the psychiatric disorders and demographic 
variables were not statistically significant predictors of the medical diseases 
(atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and type II 
diabetes). The null hypothesis was rejected. The results revealed that the presence of a 
psychiatric disorder, the type of psychiatric disorder, gender, and history of a family 
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member with a related medical disease were statistically significant predictors of the type 
of medical disorder. 
Research Question 3 
Question 3: To what degree does the presence of a psychiatric disorder as the first 
diagnosis and the diagnosed psychiatric disorder predict the medical disorders for the 
comorbid pairs included in the study? 
Null hypothesis 3: The presence of a psychiatric disorder as the first diagnosis and the 
diagnosed psychiatric disorder are not statistically significant predictors of the medical 
disorders for the comorbid pairs included in this study. 
Alternate hypothesis 3: The presence of a psychiatric disorder as the first diagnosis and 
the diagnosed psychiatric disorder are statistically significant predictors of the medical 
disorders for the comorbid pairs included in the study. 
Multinomial logistic regression was the statistical procedure used to test the full 
model of psychiatric disorders predictive accuracy in the development of the immune 
based inflammatory diseases in this study. The predictor variables were generalized 
anxiety disorder, posttraumatic stress disorder, major depression recurrent, and dysthymic 
disorder. The medical diseases were atherosclerosis, cardiovascular heart disease, 
rheumatoid arthritis, cancer, and type II diabetes. The variable ‘psychiatric diagnosis 
first’ was also an independent or predictor variable. The chi-square results from the 
omnibus tests of the model coefficients revealed X2 (16, 1,209) = 123. 334, p = .000 with 
the Nagelkerke Pseudo R-square of .110; which is a medium effect size. This finding 
indicates a statistically significant fit of the psychiatric disorders to the prediction model. 
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Further analysis also revealed that having a first diagnosis as a psychiatric disorder [X2 
(12, 1,209) = 100.133, p = .000] and the type of psychiatric disorder as the first diagnosis 
were [X2 (4, 1,209) = 24.495, p = .000] were statistically significant predictors of the 
medical disorders. Table 11 indicates that the psychiatric diagnosis of generalized anxiety 
disorder was a statistically significant predictor of cancer as the medical disease. The 
results also showed that the psychiatric diagnosis of major depression recurrent was a 
statistically significant predictor for the medical diseases of atherosclerosis, rheumatoid 
arthritis, and cancer. The overall classification accuracy for the model was 64.9%. Based 
upon the findings of the analysis, the null hypothesis was rejected. 
Table 11 
Multinomial logistic regression of medical diagnosis with psychiatric diagnosis and first  
occurring diagnosis 
 
medical 
diagnosis(a)   B 
Std. 
Error Wald df Sig. Exp(B 
95% Confidence 
Interval for Exp(B) 
                
Lower 
Bound 
Upper 
Bound 
atherosclerosis Intercept -1.924 .205 87.805 1 .000       
  [FIRSTDX=1] -.336 .184 3.326 1 .068 .715 .498 1.025 
  [PSYDX=1] -.134 .290 .214 1 .643 .874 .495 1.544 
  [PSYDX=2] .338 .442 .584 1 .445 1.402 .590 3.333 
  [PSYDX=3] 1.447 .207 48.880 1 .000 4.251 2.833 6.378 
cardiovascular 
heart disease 
Intercept 
-4.076 .572 50.767 1 .000       
  [FIRSTDX=1] -.545 .477 1.310 1 .252 .580 .228 1.475 
  [PSYDX=1] .738 .679 1.184 1 .276 2.093 .554 7.911 
  [PSYDX=2] 
-18.364 .000 . 1 . 1.058E-08 
1.058E-
08 
1.058E-
08 
  [PSYDX=3] 1.367 .599 5.207 1 .022 3.923 1.213 12.694 
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rheumatoid 
arthritis 
Intercept 
-1.249 .175 50.669 1 .000       
  [FIRSTDX=1] -.832 .189 19.284 1 .000 .435 .300 .631 
  [PSYDX=1] -.203 .248 .671 1 .413 .816 .502 1.327 
  
[PSYDX=2] 
.311 .383 .661 1 .416 1.365 .644 2.892 
  
[PSYDX=3] 
.072 .227 .101 1 .751 1.075 .689 1.676 
cancer Intercept -3.068 .304 102.178 1 .000       
  
[FIRSTDX=1] 
.283 .255 1.227 1 .268 1.327 .804 2.189 
  
[PSYDX=1] 
.729 .327 4.976 1 .026 2.073 1.092 3.934 
  
[PSYDX=2] 
.195 .642 .092 1 .762 1.215 .345 4.279 
  
[PSYDX=3] 1.412 .282 25.045 1 .000 4.104 2.361 7.135 
 
a. The reference category is: type II diabetes. 
b. Statistically significant results are boldfaced 
 
The Wald statistic was used to determine the degree to which each of the 
predictor variables, psychiatric disorders, contributed to the regression model (Mertler & 
Vannatta). The default option in SPSS used the last medical disease as the reference 
group to be used in the comparison for the results. The reference medical disease used 
was type II diabetes. As shown in Table 12, the data revealed that individuals with major 
depression as the first occurring psychiatric diagnosis had a statistically significant 
greater likelihood of developing atherosclerosis, cardiovascular heart disease, and cancer 
than type II diabetes. The results also showed that the individuals with the psychiatric 
diagnosis of generalized anxiety disorder as the first occurring diagnosis in the comorbid 
pair were statistically significantly more likely to have a medical diagnosis of cancer than 
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type II diabetes. The occurrence of the medical disease of cancer was found with both 
generalized anxiety disorder and major depression recurrent psychiatric disorders, with 
either disorder occurring first. In these instances, the occurrence was statistically 
significant compared to the occurrence of type II diabetes. 
Summary 
Chapter 4 presented the findings from the statistical analyses conducted to address 
the question of whether the presence of psychiatric disorders was predictors of the 
presence of immune based inflammatory diseases. The key variables investigated in this 
study were the presence and type of psychiatric disorder, medical disorder, psychiatric 
and medical comorbidity. The demographic variables were age, race, and gender. The 
biological variables included in the study were family history of the psychiatric disorders, 
family history of the medical disorders, and individual history of chemical dependence. 
The statistical methods used to test the prediction model were descriptive cross 
tabulation, chi-square test of independence and multinomial logistic regression. The 
analysis for this study found support from the data that certain psychiatric disorders 
predicted specific medical diseases investigated in this study. 
The first research question asked if there was an association between the first type 
of psychiatric diagnosis and the first medical diagnosis. Results from the chi-square 
analysis found that generalized anxiety disorder with type II diabetes, major depression 
recurrent with cancer, and dysthymic disorder with type II diabetes occurred at a greater 
rate than expected; therefore the null hypothesis was rejected for this question. 
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The second research question asked if the psychiatric disorders and the 
demographic and biological factors combined were statistically significant predictors of 
the medical diseases investigated in this study. The data revealed that 66.7% of the cases 
included in the study were first diagnosed with a psychiatric disorder. Results also 
revealed that the presence of psychiatric diagnosis as the first of the comorbid pair, the 
type of psychiatric diagnosis, gender, and family medical history were statistically 
significant, therefore the null hypothesis for research question 2 was rejected. The factors 
of history of chemical dependence, family history of a similar psychiatric diagnosis, and 
race were non-significant in this analysis. 
The final research question in this study inquired about the degree to which the 
presence of a psychiatric condition and the type of psychiatric condition predicted the 
presence of medical diseases included in this study. The overall classification accuracy 
rate for the model was 64.9%. The null hypothesis was rejected. 
The observed frequencies for the biological and demographic variables revealed 
possible noteworthy information regarding gender, race, and the timeline between the 
first diagnosis and the second in the comorbid condition. Chapter 5 will provide a 
discussion and summary of the study. Recommendations for professional practice and 
future research will also be presented. 
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Chapter 5: Summary, Conclusion, and Recommendations 
Introduction 
The inflammatory based immune diseases, such as atherosclerosis, cardiovascular 
heart disease, rheumatoid arthritis, cancer, and type II diabetes are responsible for the 
death of millions of individuals each year in the United States and world wide (Heijnen & 
Kavelaars, 2005; Pickup, 2003; Steptoe & Brydon, 2005; Walker, Green, Greenman, 
Walker, & Sharpe, 2005). The purpose of this study was to determine if psychiatric 
disorders were predictors of the presence of immune based inflammatory diseases. A 
major premise for this study was that if one could empirically link psychiatric disorders 
to immune based inflammatory diseases, such as atherosclerosis, cardiovascular heart 
disease, rheumatoid arthritis, cancer, and type II diabetes, then one could have a basis for 
developing and promoting additional disease prevention measures for those individuals 
who are diagnosed with certain psychiatric disorders. 
The psychiatric disorders of generalized anxiety disorder, posttraumatic stress 
disorder, major depression recurrent, and dysthymic disorder were used as possible 
predictor variables for the presence of several medical diseases. This study also included 
demographic and biological variables as possible factors that influence the occurrence of 
certain diseases. The demographic variables included, age at the first documented 
psychiatric diagnosis, age at the first documented medical disease diagnosis, and the time 
between the two diagnoses. The biological variables included, gender, race, family 
history of a similar psychiatric disorder, family history of a similar medical diagnosis, 
and history of chemical dependence. The demographic variables were also included as 
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independent variables in the prediction model. The dependent variable was the type of 
medical disorder (atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, 
cancer, and type II diabetes). 
The PNI model, which provided the theoretical basis for this study, is founded on 
the study of the relationship between emotions and the response of the nervous system to 
emotions (Rabin, 2005). The nervous system response includes changes in the production 
of certain hormones, which in turn alter immune function. The major hormones in PNI 
are cortisol, norepinephrine, and epinephrine. During instances of prolonged experiences 
of emotional distress, stress related immune impairment can occur (Kiecolt-Glaser et al., 
2002). This impairment of the immune function could result in the development of 
immune related diseases. The two most consistent emotions to trigger the immune 
response are anxiety and depression (Ader, 2005). From the classification system of 
anxiety, the present study selected the psychiatric diagnoses of generalized anxiety 
disorder and posttraumatic stress disorder. From the classification system of depression, 
the present study selected the psychiatric diagnoses of major depression recurrent and 
dysthymic disorder. 
Previous studies in PNI have investigated the relationships between a broad range 
of emotional disorders and medical diseases (Baumeister et al., 2007; Boscarino, 1997; 
Kiecolt-Glaser et al.; 2002). This study differed from many of the previous PNI related 
studies that investigated the relationship between psychiatric disorders and medical 
diseases by maintaining the distinct psychiatric and medical disease classifications 
throughout all of the analyses, rather than grouping classifications into general categories. 
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Boscarino (1997), as an example, investigated the relationship between PTSD and 
medical diseases in ten medical categories (cancer, circulatory, digestive, 
musculoskeletal, genitourinary, endocrine-nutritional-metabolic, nervous system, skin, 
respiratory, and any chronic disease). Each category was comprised of several different 
medical diagnoses that were related to the category. In addition this study differs because 
the medical diseases selected for this study were confined to the inflammatory based 
diseases for which the PNI process has been implicated by scientific research (McCance 
& Huether, 2002; Rabin, 2005). 
This chapter discusses the findings of the data analyses presented in chapter4 as 
well as an interpretation of those findings as related to the literature presented in chapter 
2. The purpose of the study, limitations, practical implications, social change 
implications, and recommendations for future research and further action are also 
presented in this chapter. 
Occurrence of Psychiatric Diagnosis and Medical Condition 
A descriptive cross tabulation statistical analysis was conducted to determine the 
number of cases in this study that had a psychiatric diagnosis as the first occurring 
diagnosis in the comorbid pairs. The data revealed that the psychiatric diagnosis occurred 
first in 67% of the cases. The data also revealed dysthymic disorder to be the most 
frequently occurring psychiatric disorder and type II diabetes to be the most frequently 
occurring medical disease. 
Principals from the PNI model can be used to explain the findings regarding the 
high number of psychiatric disorders as the first diagnosis in the comorbid pair. PNI 
106 
 
 
  
involves the study of how emotions affect the central nervous system (Rabin, 2005). 
According to the PNI model, changes in the functioning of the central nervous system in 
turn alter the immune system. Alterations in the immune system frequently serve as the 
foundation for the development of some medical diseases (McCance & Huether, 2002; 
Rabin, 2005). The present study was based upon the premise that psychiatric disorders 
may act as emotional initiators of the physiological processes that eventually lead to 
certain types of inflammatory based diseases. This study expanded upon that premise to 
investigate the predictive potential of the psychiatric disorders for the presence of specific 
inflammatory immune based diseases. 
The PNI Model and Comorbid Pairs 
In the PNI theoretical framework, the physiological response to prolonged 
emotional distress is the increased production of the hormones cortisol, epinephrine, and 
norepinephrine. These hormones contribute to the initiation of the acute inflammatory 
response. The physiological purpose of the inflammatory response is to destroy and 
remove damaged, dead, or infected cells from the body (Rabin, 2005). 
The emotionally induced physiological response resulting in atherosclerosis is the 
inflammatory response in the blood vessel walls which leads to the progressive 
dysregulation of cellular function, damage, and blockage of the blood vessel (Steptoe and 
Brydon, 2005). The blockage of blood flow in atherosclerosis can lead to stroke or heart 
attack. Cardiovascular heart disease occurs when heart muscle cells die because of lack of 
oxygen and nutrients due to blockage in the blood vessels. The inflammatory response 
works to remove the damaged heart cells. This loss of heart cells results in the 
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development of heart disease (Steptoe & Brydon, 2005). Rheumatoid arthritis is the 
failure of the immune system to recognize its own cells. This dysregulation leads to the 
tissue destroying function of the inflammatory immune response to the body’s own tissue 
that lines the joints (Heijnen & Kavelaars, 2005). Cancer is the failure of the immune 
system to detect and destroy mutated self- cells by the inflammatory response (Walker et 
al., 2005). Type II diabetes starts with the dysregulation of the blood glucose level in the 
initial stress response that progresses to the impairment of the insulin secretion of the beta 
cells of the pancreas by the acute inflammatory response (McCance & Huether, 2002; 
Pickup & Crook, 1997). 
Contrary to what was expected based on prevalence studies and previous 
literature, the results of this study showed a consistently low number of cases in the 
comorbid pairs with cardiovascular heart disease. By contrast, this study found a high 
frequency of cases with atherosclerosis. Steptoe and Brydon (2005) posit that 
atherosclerosis is not only an independent medical disease, but it is also the underlying 
disease process that can progress to cardiovascular heart disease. The results of this study 
found stronger support for the PNI theory with the medical disease of atherosclerosis. 
There were also low case counts for posttraumatic stress disorder, with the exception of 
PTSD with the diseases of type II diabetes and rheumatoid arthritis. Among all of the 
cases included in this study, there were zero cases found for the comorbid pair of PTSD 
and cardiovascular heart disease. These findings also contradict what would be expected, 
based on the PNI research presented by Boscarino (1997) and Bremner (2002) reporting a 
high prevalence of PTSD. Both researchers reported a statistically significant association 
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between PTSD and the presence of medical disease. By contrast, the pioneering work 
done by Klein (1964) in his investigation of anxiety, found that anxiety disorders have an 
endogenous biochemical bases. The present study found a high frequency of generalized 
anxiety disorder and low frequency of PTSD suggesting that further research regarding a 
possible differential PNI response to situationally induced anxiety, as with PTSD, from 
endogenous anxiety, such as generalized anxiety disorder may be warranted. 
Findings Related to Demographic Variables 
The selection of demographic variables for this study was guided by the 
limitations and recommendations reported by previous PNI researchers. A concern 
reported by Kiecolt-Glaser et al. (2002) was related to the limited type of data available 
in their archival studies. After accessing almost two-thirds of the PNI studies published 
since 1939, Kiecolt-Glaser and colleagues reported that demographic information, such 
as age, gender, race, family history of the psychiatric disorder, family history of the 
medical disease, and individual history of chemical dependence were not documented in 
the journals that they accessed. 
Kiecolt-Glaser et al. (2002) speculated that the demographic and biological data 
could contribute to the interpretation of the PNI process as related to the comorbid pairs. 
The present study did find distinct pattern differences in the comorbid presence of 
medical diseases for the demographic variables of gender, race, and age. In the present 
study, females with the psychiatric disorder of generalized anxiety disorder had the 
highest occurrence of cardiovascular heart disease, rheumatoid arthritis, cancer, and type 
II diabetes. Females with the psychiatric condition of posttraumatic stress disorder had 
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the highest rate of occurrence of rheumatoid arthritis, cancer, and type II diabetes. 
Females presenting with the diagnosis of major depression recurrent had the highest 
frequency of the medical diseases of cardiovascular heart disease, rheumatoid arthritis, 
cancer, and type II diabetes. Females with the psychiatric disorder of dysthymic disorder 
had the highest rate of occurrence of rheumatoid arthritis, cancer, and type II diabetes. 
All of these findings support the premise of PNI regarding the relationship between 
emotions, the inflammatory response, and medical diseases (Heijnen & Kavelaars, 2005; 
Pickup & Crook, 1998; Steptoe & Brydon, 2005; Walker et al, 2005). 
Among the comorbid pairs in this study, females had the highest mortality rate for 
four of the comorbid pairs. The four comorbid pairs with the highest mortality rate were 
the psychiatric disorders of generalized anxiety disorder, posttraumatic stress disorder, 
major depression recurrent, and dysthymic disorder, with each disorder being paired with 
the medical disease of cancer. The majority of the females within the high mortality rate 
in the previously mentioned comorbid pairs were European American. African American 
females had the highest rate of occurrence of posttraumatic stress disorder paired with the 
medical diseases of rheumatoid arthritis and type II diabetes. Hughes et al. (2006) 
investigated the genetic factors involved in the development of rheumatoid arthritis. 
Hughes and colleagues found that African Americans carry the nucleotide for rheumatoid 
arthritis more frequently than European Americans. In a study of three hundred thirty six 
middle-aged women with a history of depression and atherosclerosis, Jones, Bromberger, 
Sutton-Tyrrell, and Mathews (2003) found that the risk of developing vascular plaque 
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was twice as great in women who had a lifetime history of major depression recurrent 
when compared to women who had a history of single episode depression. 
The male cases in this study had the highest rate of occurrence for the comorbid 
pairs of generalized anxiety disorder, posttraumatic stress disorder, major depression 
recurrent, and dysthymic disorder, with each being paired with the medical disease of 
atherosclerosis. Males also had the highest rate of occurrence of dysthymic disorder 
paired with cardiovascular heart disease. These findings of male comorbidity associated 
with depression and heart disease are consistent with the study conducted by Ford et al 
(1998). In a forty year prospective observational study of more than 1000 male medical 
students by Ford and his colleagues (1998) at John Hopkins depression was a predictor 
for cardiovascular disease. The presence of major depression occurred as first condition 
in the 12% of the comorbid pairs and the rate of occurrence was statistically significant. 
Taylor and colleagues (2005) used a sequential logistic model to determine risk factors 
associated with the development of atherosclerosis and cardiovascular heart disease. The 
researchers found that male gender and being of European American descent were among 
the best-fit hereditary markers for the prediction of disease development. In support of 
the findings by Taylor (2005) this study found that atherosclerosis and cardiovascular 
heart disease was also most prevalent among males of European American descent. This 
study, however, did not find cardiovascular heart disease to be the most frequently 
occurring medical condition. Atherosclerosis was the medical disease that was 
statistically significant among the records of European American males. 
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Ford and his colleagues investigated major depression as the predictor of 
cardiovascular heart disease. They reported difficulty estimating the critical timing 
between the onset of the first disorder and the onset of the second disorder in the 
development of the comorbid condition (Ford et al., 1998). This study also included the 
timing between the diagnosis of the first disorder and the diagnosis of the second disorder 
as a predictor variable in the regression model. This study found that the timing between 
onset of the first disorder and onset of the second disorder occurred within one year in the 
majority of the cases in this study. 
As previously stated, this study found a greater rate of occurrence than what was 
expected by chance among the categories of psychiatric disorder occurring first in the 
comorbid conditions, and the time between the first diagnosis and the second diagnosis. 
The frequency of occurrence that exceeded expectation in the categories of age, gender, 
race, and the pattern of comorbid pairing also contributed to the breadth of this study 
because of the biological and hereditary link of these variables. No inferences, however, 
could be drawn from the analyses conducted in this study. The following section provides 
a summary and discussion of the analyses that were conducted in this study. 
Research Question 1 
Question 1: For individuals with comorbid psychiatric disorder and medical disease 
diagnoses, what is the association between the first type of psychiatric diagnosis and the 
first medical diagnosis? 
The multinomial regression analysis revealed a statistically significant 
relationship between the rate of occurrence of the psychiatric condition first and the 
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subsequent diagnosis of the comorbid condition. The data revealed the rate of occurrence 
of cases with atherosclerosis and type II diabetes occurred at a greater rate than expected 
by chance occurrence. The rates of occurrence of cases with major depression with type 
II diabetes also occurred at a greater rate than expected. In addition, the rates of 
occurrence of cases with dysthymic disorder and type II diabetes occurred at a greater 
rate than expected. Irwin and Cole (2005) discussed the PNI process with depression as 
the initiator of the inflammatory immune response. Pickup and Crook (1998) focused on 
this process as it related to type II diabetes. Steptoe and Brydon (2005) noted the 
connection between depression and atherosclerosis, with depression preceding the 
presence of atherosclerosis. As with the findings by the previous researchers, the findings 
of this study support the premise of the PNI model. 
Ford et al (1998) specifically investigated prediction with the comorbid pair of 
major depression and cardiovascular heart disease. These researchers provided one of the 
few studies designed to assess psychiatric predictors for medical disease. Ford and his 
colleagues used major depression as the predictor and cardiovascular heart disease as the 
medical condition. In a forty year, prospective observational study of over one thousand 
male medical students at John Hopkins, it was found that depression was a statistically 
significant predictor for cardiovascular heart disease. In the present study, major 
depression recurrent was a statistically significant predictor for cardiovascular heart 
disease; thus supporting previous research by Ford and colleagues. The present study also 
found that cardiovascular heart disease occurred most frequently for males than for 
females. 
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The present study found 95 cases in the major depression and atherosclerosis 
comorbid pair category. Over 55% of those cases were of individuals 50 years of age or 
older. In the present study, major depression recurrent was a statistically significant 
predictor for the development of atherosclerosis. 
In general, in the present study 78% of the cases reviewed were of individuals 
who were over fifty years of age. The present study found that 85% of the cases in the 
major depression recurrent and type II diabetes comorbid pair were of individuals 50 
years of age or over. Surwit and Schneider (1993) reported that type II diabetes is 
associated with aging. In their study of depression and type II diabetes, the researchers 
found that approximately 15% of all Americans over the age of 65 years of age develop 
type II diabetes (Surwit & Schneider, 1993). In the present study, the age factor may have 
had a confounding effect on the results regarding the high frequency of occurrence of 
type II diabetes. 
Research Question 2 
Question 2: Among individuals with comorbid psychiatric and medical disease 
diagnoses, to what degree does the presence of a psychiatric disorder and the 
demographic variables (gender, race, family psychiatric history, family medical history, 
and chemical dependence history) significantly influence the presence of the medical 
disorders atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and 
type II diabetes in the comorbid pairs? 
The null hypothesis for research question 2 was rejected. Results from the 
multinomial regression analysis revealed that the presence of a psychiatric disorder, the 
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type of psychiatric disorder, gender, and history of a family member with a related 
medical disorder were statistically significant predictors of the type of comorbid medical 
diagnosis. The presence of a psychiatric diagnosis as the first diagnosis for the comorbid 
pair and gender were statistically significant predictors of atherosclerosis. The data 
further revealed that males with a first diagnosis of major depressive disorder were 
significantly more likely to have a medical diagnosis of atherosclerosis than type II 
diabetes. The Wald statistic revealed that individuals with a first psychiatric diagnosis of 
major depression recurrent were significantly more likely to develop cardiovascular heart 
disease than type II diabetes. The data also revealed that males with a psychiatric 
disorder, who also had a family history of rheumatoid arthritis, were significantly more 
likely to have a medical diagnosis of rheumatoid arthritis than type II diabetes. The result 
further showed that males with the psychiatric diagnosis of major depression who had a 
history of chemical dependence were significantly more likely to develop cancer than 
type II diabetes. 
Ford et al. (1998) included medical risk factors for cardiovascular disease, which 
included family history and chemical dependence. Their study was designed to determine 
if major depression was an independent risk factor for coronary artery disease. After 
controlling for the known medical risk factors, Ford and his colleagues found that major 
depression was an independent risk factor for coronary artery disease. The present study 
also investigated demographic and biological factors that could influence the 
development of the comorbid condition. While gender, race, and age were significant 
factors of influence, the psychiatric disorder of major depression recurrent was found to 
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be related to the presence of the comorbid conditions of atherosclerosis and 
cardiovascular heart disease. 
A previous study by Surwit and Schneider (1993) investigated the relationship 
between stress and diabetes. The study compared diabetic patients of similar age to their 
non-diabetic siblings and neighbors. The results found that diabetic patients were 
significantly more likely to have had severe life events that lead to anxiety and depression 
than the control group. The stressful life events typically occurred within a three year 
time frame prior to the diagnosis of diabetes. The present study did not collect data 
related to life stressors, but PTSD was one of the psychiatric diagnoses investigated in the 
present study. The chi-square test of independence in Table 5 showed an association of 
68.3% between PTSD and the type II diabetes revealing type II diabetes to be the most 
frequent pairing disease with PTSD in the present study. Again, the present study found 
that the presence of a psychiatric diagnosis, the type of psychiatric diagnosis plus gender, 
and family history of a related medical diagnosis were statistically significant predictors 
of the presences of certain medical disorders. 
Research Question 3 
Question 3: To what degree does the presence of a psychiatric disorder (generalized 
anxiety disorder, posttraumatic stress disorder, major depression recurrent, and dysthymic 
disorder) as the first diagnosis and the diagnosed psychiatric disorder predict the medical 
disorders (atherosclerosis, cardiovascular heart disease, rheumatoid arthritis, cancer, and 
type II diabetes) for the comorbid pairs included in the study? 
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The null hypothesis for research question 3 was rejected. Results from the 
multinomial regression analysis revealed that the psychiatric disorders were significant 
predictors of the medical diseases. The data revealed that the psychiatric disorder 
occurring first in the comorbid pair development was a statistically significant predictor 
of the presence of medical disorders. The data further revealed that individuals with 
major depression as the first occurring psychiatric diagnosis had a statistically significant 
greater likelihood of developing atherosclerosis, cardiovascular heart disease, and cancer 
than type II diabetes. The results also showed that the individuals with the psychiatric 
diagnosis of generalized anxiety disorder as the first occurring diagnosis in the comorbid 
pair were statistically significantly more likely to have a medical diagnosis of cancer than 
type II diabetes. The occurrence of the medical disease of cancer was found with both 
generalized anxiety disorder and major depression recurrent psychiatric disorders, with 
either disorder occurring first. In these instances, the occurrence was statistically 
significant compared to the occurrence of type II diabetes. 
The findings of this study were consistent with the PNI research which has 
revealed a relationship between the presence of atherosclerosis, cancer, and type II 
diabetes with depression and or anxiety. Steptoe and Brydon (2005) present 
atherosclerosis as a vascular inflammatory process that leads to the development of 
lesions in the vascular walls. The lesions contribute to hardening of the vessels as well as 
blockage of blood flow through the vessel. The present study found that major depression 
recurrent was a statistically significant predictor for the presence of atherosclerosis, 
cancer, and type II diabetes. Findings from the current study also support research by 
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Jones et al. (2003) which also found support for the PNI model in the investigation of 
atherosclerosis in middle-aged women. They found that major depression recurrent 
resulted in a two-fold risk for the development of atherosclerosis for the 363 women 
included in their study. Results from the current study regarding atherosclerosis also 
contradict findings from Jones and colleagues which found that anxiety was not a 
predictor for atherosclerosis. As with the Jones et al. study, this study also found that 
generalized anxiety disorder and posttraumatic stress disorder were not statistically 
significant predictors of atherosclerosis. 
The PNI model for cardiovascular heart disease as presented by Steptoe and 
Brydon (2005) can be used to explain the possible connection between emotional arousal 
states such as depression or anxiety and the presence of medical diseases. With 
depression and anxiety as the initiating psychiatric condition, stress associated with the 
conditions initiate the inflammatory process and the atherosclerotic process starts.  As the 
vascular plaque builds blood flow is restricted or blocked. The restricted blood flow 
results in the restriction of oxygen and nutrients to the heart muscle. As the heart muscle 
cells become damaged or die the inflammatory response is initiated to remove the 
impaired cells. The progressive removal of the damaged heart cells is the cardiovascular 
heart disease process (Steptoe & Brydon, 2005). The present study found support for this 
PNI model, with major depression recurrent as a statistically significant psychiatric 
predictor of atherosclerosis. Ford et al. (1998) also found major depression to be a 
statistically significant predictor of cardiovascular heart disease. 
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Major depression recurrent and generalized anxiety disorder was statistically 
significant predictors for cancer in the cases in this study. Walker, Green, Greenman, 
Walker, and Sharp (2005) presented the PNI model for the development of cancer. They 
wrote that the physiological response to the prolonged psychiatric conditions of 
depression and anxiety could result in the impairment of the inflammatory response by 
the immune system. The impairment of the inflammatory response results in the failure of 
the immune system to recognize mutated self-cells. There is also a decrease in the 
production of immune system components that specifically target and rid the body of 
tumors, both benign and malignant (Walker et al., 2005). Jehn et al. (2006) conducted a 
study of 114 women who were on average 60 years of age. The researchers found that 
tumor status was associated with depression. In the study by John and colleagues, the 
level of depression was positively correlated with the progressive stage of cancer. The 
present study found the occurrence of major depression recurrent and generalized anxiety 
disorder presenting as the first diagnosis in the comorbid pair to be statistically 
significant predictors of the progressive stage of cancer. 
Positive Social Change Implications 
The social issue that this study addressed was the healthcare problem of 
psychiatric and medical disease comorbidity and the need to develop additional disease 
prevention assessment protocols. The health and quality of life for millions of individuals 
in the United States and world wide can be improved with the improvement of disease 
prevention assessments (Spiegel, 2003). The results from this study could be used to 
promote social change by contributing information regarding the relationship between the 
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comorbid psychiatric disorders and the inflammatory based medical conditions 
investigated in the study. Professionals could use the information to develop assessment 
plans that identify individuals with psychiatric conditions that are related to the comorbid 
medical diseases. Medical institutions could then develop prevention programs that 
minimize the subsequent development of the inflammatory diseases. The comprehensive 
prevention plans could encompass periodic screening for the onset of the inflammatory 
diseases, education related to the prognosis of the psychiatric disorders, as well as stress 
management techniques to manage stress associated with the psychiatric disorders. The 
overall intent of the prevention plans would be to implement preventative measures that 
interrupt or prevent the acute inflammatory response that precipitates the onset of the 
medical diseases among individuals with psychiatric disorders. 
Limitations of the Study 
This study may be difficult to replicate by researchers who do not have access to 
large healthcare facilities that use electronic medical record systems. Researchers would 
also need training on how to operate those systems. For this study, the researcher’s ability 
to work within that system was invaluable for gaining medical corroboration of the 
diagnoses, timelines of disease onset, and the demographic and clinical histories for each 
case. 
There were several factors related to this study that may limit the generalizability 
of the findings to the overall target population. First, the purposive sampling was limited 
to a single healthcare system located in Michigan. The demographic composition of 
Michigan, which is located in the northeastern region of the United States, may not be 
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representative of other regions of the country. As an example, the racial composition in 
Michigan is predominantly European American with African Americans as the second 
highest population racial group. Asian Americans comprised less than 3% of the 
Michigan population. Hispanic Americans comprise 4% of the population. Among the 
1,209 cases reviewed, 680 were European Americans (63%), 351 were African 
Americans (32%), 11 were Asian Americans, and 8 were Hispanic Americans. 
Cumulatively, the Asian American and Hispanic American comprised less than 5% of the 
cases reviewed. There were thirty cases in the ‘other’ racial category. In determining 
whether or not the sample obtained for this study was representative of the demographic 
mix in the State of Michigan, the report by the 2008 census was used for comparison. The 
comparison revealed the European Americans were underrepresented in this sample. 
African Americans were overrepresented in the sample. Asian Americans and Hispanic 
Americans were underrepresented in the sample. The representativeness of the sample 
obtained has important implications for interpreting the findings, for generalizing 
conclusions, and for suggesting future research. In addition, the use of a single healthcare 
entity from which sample cases were selected may have unique aspects that may not be 
generalizable to other healthcare facilities. 
Another factor was the study inclusion criteria which limited the cases reviewed 
to adults 21 years of age and older. Comorbid conditions of children and adolescents 
were not included in the study. The age of the individuals whose cases were reviewed 
was predominantly 50 years of age and over. Age may have had a confounding effect on 
the study because of possible age related medical conditions. Finally, the five year 
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population cycle for this study may not have been sufficient to detect the presence of the 
psychiatric disorder and medical disease comorbid condition among the cases not 
included in the study. 
Recommendations for Action 
In a study conducted by Wells, Rogers, Burnam, Greenfield, and Ware (1991) it 
was reported that patients with psychiatric disorders are treated in a variety of clinical 
settings. Those settings range from the general medicine physician to outpatient 
psychiatry. Therefore all healthcare sectors need to be informed of the psychiatric 
predictors for medical disease. Based upon the findings of this study it is recommended 
that patients with the diagnosis of major depression recurrent or generalized anxiety 
disorder to have on-going screenings for elevations in the inflammatory bio-immune 
markers for atherosclerosis, rheumatoid arthritis, cancer, and type II diabetes. In addition, 
those patients identified with these psychiatric disorders will need information regarding 
the possible health risk for the development of a comorbid disorder and the possible 
benefit of psychotherapy support. 
There are several avenues available for the dissemination of the findings of this 
study. For the purpose of initiating a positive social change within a single healthcare 
organization, the healthcare system that was the research site for this study would be the 
first organization to approach. The organization had requested a copy of the results before 
the start of the study. The healthcare system also has a procedural track in place to 
consider innovative, evidence-based practices. This would be the appropriate venue to 
introduce a new disease prevention assessment approach. This researcher had the 
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privilege of serving on one of the committees from 2005 to 2007. The recommendations 
generated by the committee were implemented. In a broader spectrum, the healthcare 
system produces the PBS television program Minds of Medicine. This program is shown 
nation wide and it has won several Emmy awards for excellence. The purpose of the 
program is to present research conducted within the system and inform other healthcare 
organizations of the findings. Another means for disseminating the results could be 
through the American Psychological Association, of which the researcher is a member. 
The APA publishes over 60 journals. The APA encourages articles based on graduate 
research conducted by its members in an effort to encourage new researchers. Two of the 
journals that may be appropriate for this study are The American Psychologist and 
Psychological Review. 
Recommendations for Further Study 
A retrospective cohort longitudinal study using the medical records identified for 
this research, those patients identified with the psychiatric disorder who did not develop 
an inflammatory based disease compared to those who did develop the disease would be 
of benefit. It would be of interest to determine if the successful completion of 
psychotherapy was a statistically significant factor among either of the two groups with 
regard to the presence of disease. The review of psychotherapy utilization over time for 
patients with the psychiatric comorbidities and those who did not develop medical 
disease can address key treatment issues in PNI research regarding the assumption that 
psychotherapy will have a significant effect on medical disease prevention. 
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A prospective longitudinal study would be useful in further investigations of 
prediction in comorbidity development and analyzing psychiatric diagnoses as predictors. 
The present study could not provide information regarding the timing of disease onset, 
only the first documented disorder. A prospective study could make a contribution to this 
area of research.  
Also in this study, the demographic characteristics of the cases reviewed suggest 
the need for further studies of the European American population because of the high 
comorbidity rate in that group. Even though the demographic mix of the sample in this 
study revealed this population to be underrepresented, those factors did not appear to 
influence the case distribution among the different comorbid pairs. In those distributions, 
the European Americans were dominant in the psychiatric diagnoses groups that were 
statistically significant predictors for the presence of disease. Those comorbid groups also 
had the highest mortality rates. Gender and age were also significant demographic 
factors. Future PNI studies should continue to include the factors of age, gender, and race 
to provide further information regarding these findings. 
Finally, the availability of electronic medical records was an invaluable resource 
for this study. It is the recommendation to have more studies conducted using electronic 
medical records to gain documented clinical data with confirmed psychiatric and medical 
diagnoses. 
Conclusions 
This study was conducted to investigate the predictive potential for certain 
psychiatric disorders to predict the development of specific medical diseases. This study 
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accomplished identifying major depression recurrent and generalized anxiety disorder as 
statistically significant predictors for atherosclerosis, cancer, and type II diabetes. The 
observed frequencies for the biological and demographic variables revealed  noteworthy 
information. National prevalence studies have reported high mortality rates among 
individuals suffering from psychiatric and medical disease comorbidity. The present 
study found the same occurrence of high mortality. As an example, in 14 of the 19 
comorbid pairs the mortality rate ranged from 30% to 73.7% among the majority of the 
comorbid pairs (table 4). Based upon the findings of this study it is recommended that 
patients with the diagnosis of major depression recurrent or generalized anxiety disorder 
to have on-going screenings for elevations in the inflammatory bio-immune markers for 
atherosclerosis, rheumatoid arthritis, cancer, and type II diabetes. In addition, those 
patients with these psychiatric diagnoses will need information regarding the possible 
health risk for the development of a comorbid disorder and the possible benefit of 
psychotherapy support. 
The psychiatric disorder as a predictor for medical disease model in this study 
offers direct, immediate application in healthcare practice. The findings of this study also 
offer specific direction for future research. The ultimate goal is to reduce the disability 
and death suffered by millions of individuals by increasing disease prevention assessment 
options and approaches. 
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Appendix A:  Data Based Search Sheet 
 
Table 1 
Participant Data Search Sheet with DSM-VI and ICD-9 Codes for the Comorbid Pairs 
------------------------------------------------------------------------------------------------------------
Comorbid Pair                       DSM-IV plus ICD-9 Code 
------------------------------------------------------------------------------------------------------------
general anxiety disorder and atherosclerosis           [300.02 plus 440.9] 
generalized anxiety disorder and cardiovascular heart disease    [300.02 plus 429.2] 
generalized anxiety disorder and rheumatoid arthritis       [300.02 plus 714.0] 
generalized anxiety disorder and cancer             [300.02 plus 199.1] 
generalized anxiety disorder and type II diabetes         [300.02 plus 250.02] 
posttraumatic stress disorder and atherosclerosis         [309.81 plus 440.9] 
posttraumatic stress disorder and cardiovascular heart disease   [309.81 plus 429.2] 
posttraumatic stress disorder and rheumatoid arthritis       [309.81 plus 714.0] 
posttraumatic stress disorder and cancer             [309.81 plus 199.1] 
posttraumatic stress disorder and type II diabetes        [309.81 plus 250.02] 
major depression recurrent and atherosclerosis          [296.3 plus 440.9] 
major depression recurrent and cardiovascular heart disease     [296.3 plus 429.2] 
major depression recurrent and rheumatoid arthritis        [296.3 plus 714.0] 
major depression recurrent and cancer              [296.3 plus 199.1] 
major depression recurrent and type II diabetes          [296.3 plus 250.02] 
dysthymic disorder and atherosclerosis              [300.4 plus 440.9] 
dysthymic disorder and cardiovascular heart disease        [300.4 plus 429.2] 
dysthymic disorder and rheumatoid arthritis            [300.4 plus 714.0] 
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dysthymic disorder and cancer                  [300.4 plus 199.1] 
dysthymic disorder and type II diabetes              [300.4 plus 250.02] 
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Appendix B:  Coding System for Study Variables 
 
First Diagnosis Psychiatric (firstdx) 
Yes = 1 
No = 2 
Time Between Diagnoses (timedx) 
1 to 5 Years = 1 
6 to 10 years = 2 
Beyond 10 years = 3 
 
Chemical Dependence History (cdhx) 
Yes = 1 
No = 2 
Family History of Psychiatric Diagnosis (fampsyc) 
Yes = 1 
No = 2 
Family History of Medical Diagnosis (fammed) 
Yes = 1 
No = 2 
Gender (gender) 
Male = 1 
Female = 2 
Race/Ethnicity (raceeth) 
Asian American = 1 
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African American = 2 
European American   = 3 
Hispanic American = 4 
Psychiatric Medical Comorbidity (psymed) 
generalized anxiety disorder and atherosclerosis = 1 
generalized anxiety disorder and cardiovascular heart disease = 2 
generalized anxiety disorder and rheumatoid arthritis = 3 
generalized anxiety disorder and cancer = 4 
generalized anxiety disorder and Type II diabetes = 5 
posttraumatic stress disorder and atherosclerosis = 6 
posttraumatic stress disorder and cardiovascular heart disease = 7 
posttraumatic stress disorder and rheumatoid arthritis = 8 
posttraumatic stress disorder and cancer = 9 
posttraumatic stress disorder and Type II diabetes = 10 
major depression recurrent and atherosclerosis = 11 
major depression recurrent and cardiovascular heart disease = 12 
major depression recurrent and rheumatoid arthritis = 13 
major depression recurrent and cancer = 14 
major depression recurrent and Type II diabetes = 15 
Dysthymic disorder and atherosclerosis = 16 
Dysthymic disorder and cardiovascular heart disease = 17 
Dysthymic disorder and rheumatoid arthritis = 18 
Dysthymic disorder and cancer = 19 
Dysthymic disorder and Type II diabetes = 20 
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 Appendix C 
Frequency Descriptive of Comorbid Pairs from the First Data base Search  
------------------------------------------------------------------------------------------------------------ 
Comorbid pair                       _____________________________________        n 
Cases found for Generalized Anxiety Disorder: N = 1,458 
generalized anxiety disorder/atherosclerosis                                                           1 
generalized anxiety disorder/cardiovascular heart disease                                      0 
generalized anxiety disorder/rheumatoid arthritis                                                   4 
generalized anxiety disorder/cancer                                                                        4 
generalized anxiety disorder/type II diabetes                                                        49 
Cases found for Posttraumatic Stress Disorder: N = 263 
posttraumatic stress disorder/atherosclerosis                                                          2 
posttraumatic stress disorder/cardiovascular heart disease                                     0 
posttraumatic stress disorder/rheumatoid arthritis                                                  2 
posttraumatic stress disorder/cancer                                                                       0 
posttraumatic stress disorder/type II diabetes                                                        11 
Cases found for Major Depression Recurrent: N = 4,918 
major depression recurrent/atherosclerosis                                                           12 
major depression recurrent/cardiovascular heart disease                                        2 
major depression recurrent/rheumatoid arthritis                                                   36 
major depression recurrent/cancer                                                                          4 
major depression recurrent/type II diabetes                                                          287 
Cases Found for Dysthymic Disorder: N = 1,494 
dysthymic disorder/atherosclerosis                                                                         0 
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dysthymic disorder/cardiovascular heart disease                                               1 
dysthymic disorder/rheumatoid arthritis                                                            6 
dysthymic disorder/cancer                                                                                 1 
dysthymic disorder/type II diabetes                                                                  61 
------------------------------------------------------------------------------------------------------------
-- 
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working with school systems on behalf of the children. 
 Integrity Stress Management Program – Detroit, Mi. Individual therapy to adults in a 
private practice facility. 
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 Southwest Detroit Community Mental Health – Detroit, Mi. Psychotherapy for chronic 
mentally ill adults and dual diagnosed patients provided. Special Project: Co-therapist for 
the SAMI Program (Substance Abuse/Mentally Ill) with recognition received because of 
a significant decrease in number of patient requiring psychiatric hospitalization for a five 
year period of time. 
 Bazini Oak Clinic – Oakwood Hospital, Dearborn, Mi. Part-time general private practice 
under the supervision of psychiatrist, Dr. Bazini. Psychotherapy for children, adults, and 
families provided. 
 Community Care Services, CMH - Lincoln Park, Mi. Therapist in the Women’s 
Intensive Outpatient Program for treatment of women who are chemically dependent. 
 Henry Ford Health System – Maplegrove Center – West Bloomfield, Mi. Inpatient Dept. 
Treatment of chemically dependent and dual diagnosed adults. Provide new patient 
evaluations and assessments, individual, group, and family therapy sessions and lectures. 
Special Project: Development of self-help program for anger management. 
